Notes to Consolidated Financial Statements
Note 1. Summary of Significant Accounting Policies
a. Basis of Presentation and Nature of Operations
The consolidated financial statements of Aerojet Rocketdyne Holdings, Inc. ("Aerojet Rocketdyne Holdings" or the "Company") include the accounts of the Company and its 100% owned and majority owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to financial information for prior years to conform to the current year’s presentation.
The Company’s operations are organized into two segments:
Aerospace and Defense — includes the operations of the Company’s wholly-owned subsidiary Aerojet Rocketdyne, Inc. ("Aerojet Rocketdyne"), a leading technology-based designer, developer and manufacturer of aerospace and defense products and systems for the United States ("U.S.") government, including the Department of Defense ("DoD"), the National Aeronautics and Space Administration ("NASA"), and major aerospace and defense prime contractors.
Real Estate — includes the activities of the Company’s wholly-owned subsidiary Easton Development Company, LLC ("Easton") related to the re-zoning, entitlement, sale, and leasing of the Company’s excess real estate assets.
The year of the Company's subsidiary, Aerojet Rocketdyne, ends on the last Saturday in December.
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Terminated Merger Agreement
On December 20, 2020, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lockheed Martin Corporation ("Lockheed Martin") and Mizar Sub, Inc., a wholly-owned subsidiary of Lockheed Martin ("Merger Sub"), pursuant to which each share of common stock of the Company would have been automatically converted into the right to receive cash in an amount equal to $51.00 per share, adjusted from $56.00 following the payment of a one-time cash dividend of $5.00 per share paid in March 2021 (the "Pre-Closing Dividend") and the Company would have become a wholly-owned subsidiary of Lockheed Martin (the "Merger").
On January 25, 2022, the Federal Trade Commission ("FTC") filed a complaint against the Company and Lockheed Martin in the FTC’s administrative court and a complaint in U.S. federal court seeking a preliminary injunction to stop the deal pending an administrative trial (the "FTC Litigation"). On February 13, 2022, Lockheed Martin notified the Company that it had elected to terminate the Merger Agreement. On February 14, 2022, pursuant to the parties’ joint motion, the administrative complaint and the U.S. federal court complaint were dismissed.
Coronavirus ("COVID-19") Pandemic
During 2021, the Company’s financial results and operations were not materially adversely impacted by the COVID-19 pandemic. As a defense industrial-base U.S. government contractor, the Company is considered an essential business by the U.S. and state governments and it continues to operate as such during the COVID-19 pandemic. The extent to which the Company’s future financial results could be impacted by COVID-19 pandemic depends on future developments that are highly uncertain and cannot be predicted at this time. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Annual Report on Form 10-K. These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.
b. Cash and Cash Equivalents
All highly liquid debt instruments purchased with a remaining maturity at the date of purchase of three months or less are considered to be cash equivalents. The Company aggregates its cash balances by bank, and reclassifies any negative balances, if applicable, to other current liabilities.
c. Restricted Cash
As of December 31, 2021 and 2020, the Company designated $3.0 million as restricted cash to satisfy indemnification obligations for environmental remediation coverage.
d. Fair Value of Financial Instruments
Financial instruments are classified using a three-tiered fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as
unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. | | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair value measurement as of December 31, 2021 |
| Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Other Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| (In millions) |
Money market funds | $ | 388.6 | | | $ | 388.6 | | | $ | — | | | $ | — | |
Commercial paper | 35.0 | | | — | | | 35.0 | | | — | |
Registered investment companies | 1.3 | | | 1.3 | | | — | | | — | |
Equity securities | 10.6 | | | 10.6 | | | — | | | — | |
| | | | | | | |
Total | $ | 435.5 | | | $ | 400.5 | | | $ | 35.0 | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair value measurement as of December 31, 2020 |
| Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Other Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| (In millions) |
Money market funds | $ | 569.3 | | | $ | 569.3 | | | $ | — | | | $ | — | |
Commercial paper | 232.0 | | | — | | | 232.0 | | | — | |
Registered investment companies | 2.5 | | | 2.5 | | | — | | | — | |
Equity securities | 7.0 | | | 7.0 | | | — | | | — | |
Total | $ | 810.8 | | | $ | 578.8 | | | $ | 232.0 | | | $ | — | |
As of December 31, 2021 and 2020, the total estimated fair value for commercial paper was classified as cash and cash equivalents as the remaining maturity at date of purchase was less than three months. Unrealized gains on equity securities (component of interest income in the consolidated statements of operations) in 2021 and 2020 totaled $1.5 million and $0.3 million, respectively.
The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued compensation, and other accrued liabilities, approximate fair value because of their short maturities.
The following table summarizes the estimated fair value and principal amount for outstanding debt obligations excluding finance lease obligations:
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value | | Principal Amount |
| As of December 31, | | As of December 31, |
| 2021 | | 2020 | | 2021 | | 2020 |
| | | | | | | |
| (In millions) |
Term loan | $ | 275.8 | | | $ | 306.5 | | | $ | 282.2 | | | $ | 308.5 | |
| | | | | | | |
| | | | | | | |
2.25% Convertible Senior Notes ("2 1/4% Notes") | 266.1 | | | 609.5 | | | 145.9 | | | 300.0 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| $ | 541.9 | | | $ | 916.0 | | | $ | 428.1 | | | $ | 608.5 | |
The fair value of the 2¼% Notes was determined using broker quotes that are based on open markets for the Company's debt securities (Level 2 securities). The fair value of the term loan was estimated based on a third-party model used to derive a relative value price using comparable corporate loans within a similar industry, credit quality, and currency.
e. Accounts Receivable
Accounts Receivable represent the Company's unconditional right to consideration under the contract and include amounts billed and currently due from long-term contract customers. The amounts are stated at their net estimated realizable value.
Other receivables represent amounts billed for revenue not derived from long-term contracts.
f. Inventories
Inventories are stated at cost (generally using the average cost method) or net realizable value. The Company capitalizes costs incurred in advance of contract award or funding in inventories if it determines that contract award or funding is probable. Amounts previously capitalized are expensed when changes in facts and circumstances indicate that a contract award or funding is no longer probable. General and administrative costs incurred throughout 2021 and 2020 totaled $237.1 million and $262.9 million, respectively, and the cumulative amount of general and administrative costs in long-term contract inventories were
estimated to be $1.3 million and $1.8 million as of December 31, 2021 and 2020, respectively. Inventories are included as a component of other current assets.
g. Income Taxes
The Company files a consolidated U.S. federal income tax return with its 100% owned consolidated subsidiaries. The deferred tax assets and/or liabilities are determined by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the period of the enactment date of the change.
The carrying value of the Company’s deferred tax assets is dependent upon its ability to generate sufficient taxable income in the future. A valuation allowance is required when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence is considered, including the Company’s past and future performance, the market environment in which it operates, the utilization of tax attributes in the past, the length of carryback and carryforward periods, and evaluation of potential tax planning strategies.
h. Property, Plant and Equipment, net
Property, plant and equipment are recorded at cost. Refurbishment costs that extend the life or increase the value of an asset are capitalized in the property accounts, whereas ordinary maintenance and repair costs are expensed as incurred. Depreciation is computed principally by accelerated methods based on the following useful lives:
| | | | | |
Buildings and improvements | 9 - 40 years |
Machinery and equipment | 6 - 10 years |
Costs related to software acquired, developed or modified solely to meet the Company's internal requirements (including cloud computing arrangements) and for which there are no substantive plans to market for sale are capitalized and depreciated over 3 to 7 years. Only costs incurred after the preliminary planning stage of the project and after management has authorized and committed funds to the project are eligible for capitalization.
i. Leases
The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ("ROU") assets, other current liabilities, and operating lease liabilities. Finance leases are included in property, plant and equipment and debt. Operating ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Finance leases are recorded as an asset and an obligation at an amount equal to the present value of the minimum lease payments during the lease term. Amortization expense related to finance leases is included in depreciation and amortization expense.
For certain technology equipment leases, the Company accounts for lease and nonlease (service) components separately based on a relative fair market value basis. For all other leases, the Company accounts for the lease and nonlease components (e.g., common area maintenance) on a combined basis.
The discount rate used for leases is the Company's incremental borrowing rate for collateralized debt based on information available at the lease commencement date. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. Leases with a term of twelve months or less and that do not include a purchase option that is likely to be exercised are treated as short-term leases and are not reflected on the balance sheet. The Company leases certain facilities, machinery and equipment (including information technology equipment), and office buildings under long-term, non-cancelable operating and finance leases.
j. Real Estate Held for Entitlement and Leasing
The Company capitalizes all costs associated with the real estate entitlement and leasing process. The Company classifies activities related to the entitlement, sale, and leasing of its excess real estate assets as operating activities in the consolidated statements of cash flows. Real estate held for entitlement and leasing is included as a component of other noncurrent assets.
k. Goodwill
Goodwill represents the excess of the purchase price of an acquired enterprise or assets over the fair values of the identifiable assets acquired and liabilities assumed. All of the Company's recorded goodwill resides in the Aerospace and Defense reporting unit. Tests for impairment of goodwill are performed on an annual basis, or at any other time if events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Circumstances that could trigger an impairment test include but are not limited to: a significant adverse change in the business climate or legal factors; adverse cash flow trends; an adverse action or assessment by a regulator; unanticipated competition; loss of key personnel; decline in stock price; and results of testing for recoverability of a significant asset group within a reporting unit.
The Company evaluates qualitative factors (including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance) to determine whether it is necessary to perform the first step of the goodwill test. This step is referred to as the "Step Zero" analysis. If it is determined that it is more likely than not (a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount, the Company will proceed to the quantitative ("Step One") analysis to determine the existence and amount of any goodwill impairment. The Company may also perform a Step One
analysis from time to time to augment its qualitative assessment. The Company evaluated goodwill using a Step Zero analysis as of October 1, 2021 and 2020, and determined that goodwill was not impaired.
There can be no assurance that the Company’s estimates and assumptions made for purposes of its goodwill impairment testing will prove to be accurate predictions of the future. If the Company’s assumptions and estimates are incorrect, the Company may be required to record goodwill impairment charges in future periods.
The goodwill balance as of December 31, 2021 and 2020, relates to the Company’s Aerospace and Defense segment.
l. Intangible Assets
Identifiable intangible assets, such as patents, trademarks, and licenses are recorded at cost or when acquired as part of a business combination at estimated fair value. Identifiable intangible assets are amortized based on when they provide the Company economic benefit, or using the straight-line method, over their estimated useful life. Amortization periods for identifiable intangible assets range from 7 years to 30 years.
m. Environmental Remediation
The Company expenses, on a current basis, recurring costs associated with managing hazardous substances and contamination in ongoing operations. The Company reviews on a quarterly basis estimated future remediation costs and has an established practice of estimating environmental remediation costs over a fifteen-year period, except for those environmental remediation costs with a specific contractual term. Environmental liabilities at the Baldwin Park Operable Unit ("BPOU") site are currently estimated through the term of the project agreement, which expires in May 2027. In establishing reserves, the most probable estimated amount is used when determinable, and the minimum amount is used when no single amount in the range is more probable. Environmental reserves include the costs of completing remedial investigation and feasibility studies, remedial and corrective actions, regulatory oversight costs, the cost of operation and maintenance of the remedial action plan, and employee compensation costs for employees who are expected to devote a significant amount of time to remediation efforts. Calculation of environmental reserves is based on the evaluation of currently available information with respect to each individual environmental site and considers factors such as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. Such estimates are based on the expected costs of investigation and remediation and the likelihood that other potentially responsible parties will be able to fulfill their commitments at sites where the Company may be jointly or severally liable.
At the time a liability is recorded for future environmental costs, the Company records an asset for estimated future recoveries that are estimable and probable. Some of the Company’s environmental costs are eligible for future recovery in the pricing of its products and services to the U.S. government and under existing third party agreements. The Company considers the recovery probable based on the Global Settlement, U.S. government contracting regulations, and its long history of receiving reimbursement for such costs (see Notes 8(b) and 8(c)).
n. Retirement Benefits
The Company discontinued future benefit accruals for the defined benefit pension plans in 2009. The Company provides medical and life insurance benefits ("postretirement benefits") to certain eligible retired employees, with varied coverage by employee group. Annual charges are made for the cost of the plans, including interest costs on benefit obligations, and net amortization and deferrals, increased or reduced by the return on assets. The Company also sponsors a defined contribution 401(k) plan and participation in the plan is available to all employees (see Note 7).
o. Conditional Asset Retirement Obligations
Conditional asset retirement obligations ("CAROs") are legal obligations associated with the retirement of long-lived assets. These liabilities are initially recorded at fair value and the expected asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, the Company records period-to-period changes in the CARO liability resulting from the passage of time and revisions to either the timing or the amount of the estimate of the undiscounted cash flows.
CAROs associated with owned properties are based on estimated costs necessary for the legally required removal or remediation of various regulated materials, primarily asbestos disposal and radiological decontamination of an ordnance manufacturing facility. For leased properties, CAROs are based on the estimated cost of contractually required property restoration.
The following table summarizes the changes in the carrying amount of CAROs: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
Balance at beginning of year | $ | 51.4 | | | $ | 51.4 | | | $ | 46.0 | | | |
(Reductions)/ additions and other, net | (2.3) | | | (2.7) | | | 2.6 | | | |
Accretion | 2.7 | | | 2.7 | | | 2.8 | | | |
Balance at end of year | $ | 51.8 | | | $ | 51.4 | | | $ | 51.4 | | | |
| | | | | | | |
p. Loss Contingencies
The Company is currently involved in certain legal proceedings and has accrued its estimate of the probable costs and recoveries (in relation to environmental costs) for resolution of these claims. These estimates are based upon an analysis of potential results, assuming a combination of litigation and settlement strategies. It is possible, however, that future results of operations or cash flows for any particular period could be materially affected by changes in estimates or the effectiveness of strategies related to these proceedings.
q. Warranties
The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are a one-year standard warranty for parts, workmanship, and compliance with specifications. On occasion, the Company has made commitments beyond the standard warranty obligation. While the Company has contracts with warranty provisions, there is not a history of any significant warranty claims experience. A reserve for warranty exposure is made on a product by product basis when it is both estimable and probable. These costs are included in the program’s estimate at completion and are expensed in accordance with the Company’s revenue recognition methodology for that particular contract.
r. Revenue Recognition
In the Company’s Aerospace and Defense segment, the majority of revenue is earned from long-term contracts to design, develop, and manufacture aerospace and defense products for, and provide related services to, the Company’s customers, including the U.S. government and major aerospace and defense prime contractors. Each customer contract defines the Company’s distinct performance obligations and the associated transaction price for each obligation. A contract may contain one or multiple performance obligations. In certain circumstances, multiple contracts with a customer are required to be combined in determining the distinct performance obligation. For contracts with multiple performance obligations, the Company allocates the contracted transaction price to each performance obligation based upon the relative standalone selling price, which represents the price at which the Company would sell the promised good or service separately to the customer. The Company determines the standalone selling price based upon the facts and circumstances of each obligated good or service. The majority of the Company’s contracts have no observable standalone selling price since the associated products and services are customized to customer specifications. As such, the standalone selling price generally reflects the Company’s forecast of the total cost to satisfy the performance obligation plus an appropriate profit margin.
Contract modifications are routine in the performance of the Company's long-term contracts. Contracts are often modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and, therefore, are accounted for as part of the existing contract.
The Company recognizes revenue as each performance obligation is satisfied. The majority of the Company’s aerospace and defense performance obligations are satisfied over time either as the service is provided, or as control transfers to the customer. Transfer of control is evidenced by the Company’s contractual right to payment for work performed to date plus a reasonable profit on contracts with highly customized products that have no alternative use to the Company. The Company measures progress on substantially all its performance obligations using the cost-to-cost method, which the Company believes best depicts the transfer of control of goods and services to the customer. Under the cost-to-cost method, the Company records revenues based upon costs incurred to date relative to the total estimated cost at completion. Contract costs include labor, material, overhead, and general and administrative expenses, as appropriate.
Recognition of revenue and profit on long-term contracts requires the use of assumptions and estimates related to the total contract value, the total cost at completion, and the measurement of progress towards completion for each performance obligation. Due to the nature of the programs, developing the estimated total contract value and total cost at completion for each performance obligation requires the use of significant judgment.
The contract value of long-term contracts may include variable consideration, such as incentives, awards, or penalties. The value of variable consideration is generally determined by contracted performance metrics, which may include targets for cost, performance, quality, and schedule. The Company includes variable consideration in the transaction price for the respective performance obligation at either estimated value, or most likely amount to be earned, based upon the Company’s assessment of expected performance. The Company records these amounts only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
The Company evaluates the contract value and cost estimates for performance obligations at least quarterly and more frequently when circumstances significantly change. Factors considered in estimating the work to be completed include, but are
not limited to: labor productivity, the nature and technical complexity of the work to be performed, availability and cost volatility of materials, subcontractor and vendor performance, warranty costs, volume assumptions, anticipated labor agreements, inflationary trends, schedule and performance delays, availability of funding from the customer, and the recoverability of costs incurred outside the original contract included in any estimates to complete. When the Company’s estimate of total costs to be incurred to satisfy a performance obligation exceeds the expected revenue, the Company recognizes the loss immediately. When the Company determines that a change in estimates has an impact on the associated profit of a performance obligation, the Company records the cumulative positive or negative adjustment to the statement of operations. Changes in estimates and assumptions related to the status of certain long-term contracts may have a material effect on the Company’s operating results. The following table summarizes the impact of the changes in significant contract accounting estimates on the Company’s Aerospace and Defense segment operating results: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions, except per share amounts) |
Net favorable effect of the changes in contract estimates on net sales | $ | 34.8 | | | $ | 38.5 | | | $ | 38.6 | | | |
Favorable effect of the changes in contract estimates on income before income taxes | 31.2 | | | 45.1 | | | 38.4 | | | |
Favorable effect of the changes in contract estimates on net income | 23.0 | | | 34.5 | | | 28.2 | | | |
Favorable effect of the changes in contract estimates on basic earnings per share ("EPS") of common stock | 0.29 | | | 0.44 | | | 0.36 | | | |
Favorable effect of the changes in contract estimates on diluted EPS | 0.28 | | | 0.42 | | | 0.34 | | | |
| | | | | | | |
The 2021 net favorable changes in contract estimates were primarily driven by improved performance and risk retirements on the RS-68, Terminal High Altitude Area Defense ("THAAD"), Patriot Advanced Capability-3 ("PAC-3"), and RL10 programs partially offset by cost growth on a portion of the Standard Missile program and the Commercial Crew program. The 2020 net favorable changes in contract estimates were primarily driven by improved performance and risk retirements on the THAAD, RS-68, RL10, and PAC-3 programs partially offset by cost growth on a portion of the Standard Missile program and the Commercial Crew program. The 2019 net favorable changes in contract estimates on income before income taxes were primarily driven by improved performance and risk retirements on the THAAD and PAC-3 programs.
In the Company’s Aerospace and Defense segment, the timing of revenue recognition, customer invoicing, and collections produces accounts receivable, contract assets, and contract liabilities on the Company’s Consolidated Balance Sheet. The Company invoices in accordance with contract payment terms either based upon a recurring contract payment schedule, or as contract milestones are achieved. Customer invoices, net of reserves, represent an unconditional right of consideration. When revenue is recognized in advance of customer invoicing, a contract asset is recorded. Conversely, when customers are invoiced in advance of revenue recognition, a contract liability is recorded. Unpaid customer invoices are reflected as accounts receivable. Amounts for overhead disallowances or billing decrements are reflected in contract assets and primarily represent estimates of potential overhead costs which may not be successfully negotiated and collected. The following table summarizes contract assets and liabilities:
| | | | | | | | | | | | | |
| As of December 31, |
| 2021 | | | | 2020 |
| (In millions) |
Contract assets | $ | 359.6 | | | | | $ | 294.3 | |
Reserve for overhead rate disallowance | (5.4) | | | | | (5.7) | |
Contract assets, net of reserve | 354.2 | | | | | 288.6 | |
Contract liabilities | 366.5 | | | | | 407.2 | |
Net contract liabilities, net of reserve | $ | (12.3) | | | | | $ | (118.6) | |
| | | | | |
| | | | | |
Net contract liabilities decreased by $106.3 million primarily due to a decrease in contract advances and an increase in unbilled receivables. During 2021, the Company recognized sales of $364.9 million that were included in the Company’s contract liabilities as of December 31, 2020. During 2020, the Company recognized sales of $222.3 million that were included in the Company’s contract liabilities as of December 31, 2019. Contract assets included unbilled receivables of $347.1 million and $286.0 million as of December 31, 2021 and 2020, respectively. Approximately 20% of unbilled receivables at December 31, 2021, are expected to be collected after one year.
As of December 31, 2021, the Company’s total remaining performance obligations, also referred to as backlog, totaled $6.8 billion. The Company expects to recognize approximately 34%, or $2.3 billion, of the remaining performance obligations as sales over the next twelve months, an additional 28% the following twelve months, and 38% thereafter.
The Company's contracts are largely categorized as either "fixed-price" (largely used by the U.S. government for production-type contracts) or "cost-reimbursable" (largely used by the U.S. government for development-type contracts). Fixed-price contracts present the risk of unreimbursed cost overruns, potentially resulting in lower than expected contract profits and margins. This risk is generally lower for cost-reimbursable contracts which, as a result, generally have a lower margin. The following table summarizes the percentages of net sales by contract type:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
Fixed-price | 57 | % | | 61 | % | | 61 | % | | |
Cost-reimbursable | 43 | | | 39 | | | 39 | | | |
| | | | | | | |
Revenue from real estate asset sales is recognized when a sufficient down-payment has been received, financing has been arranged and title, possession and other attributes of ownership have been transferred to the buyer. The allocation to cost of sales on real estate asset sales is based on a relative fair market value computation of the land sold which includes the basis on the Company’s book value, capitalized entitlement costs, and an estimate of the Company’s continuing financial commitment.
s. Research and Development ("R&D")
Company-funded R&D expenses (reported as a component of cost of sales) were $50.6 million, $55.8 million, and $65.1 million in 2021, 2020, and 2019, respectively. Company-funded R&D expenses include the costs of technical activities that are useful in developing new products, services, processes, or techniques, as well as expenses for technical activities that may significantly improve existing products or processes. These expenses are generally allocated among all contracts and programs in progress under U.S. government contractual arrangements. From time to time, the Company believes it is in its best interests to self-fund and not allocate costs for certain R&D activities to the U.S. government contracts.
Customer-funded R&D expenditures, which are funded from U.S. government contracts, totaled $700.7 million, $628.7 million, and $680.5 million in 2021, 2020, and 2019, respectively. Expenditures under customer-funded R&D U.S. government contracts are accounted for as sales and cost of sales.
t. Stock-based Compensation
The Company recognizes stock-based compensation in the statements of operations at the grant-date fair value of stock awards issued to employees and directors over the vesting period. The Company also grants Stock Appreciation Rights ("SARs") awards which are similar to the Company’s employee stock options, but are settled in cash rather than in shares of common stock, and are classified as liability awards. Compensation cost for these awards is determined using a fair-value method and remeasured at each reporting date until the date of settlement. The Company accounts for forfeitures when they occur for consistency with the U.S. government recovery accounting practice.
u. Impairment or Disposal of Long-Lived Assets
Impairment of long-lived assets is recognized when events or circumstances indicate that the carrying amount of the asset, or related groups of assets, may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; or a current expectation that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the Company determines that an asset is not recoverable, then the Company would record an impairment charge if the carrying value of the asset exceeds its fair value.
A long-lived asset classified as "held for sale" is initially measured at the lower of its carrying amount or fair value less costs to sell. In the period that the "held for sale" criteria are met, the Company recognizes an impairment charge for any initial adjustment of the long-lived asset amount. Gains or losses not previously recognized resulting from the sale of a long-lived asset are recognized on the date of sale.
v. Concentrations
Dependence upon U.S. Government Programs and Contracts
The principal end user customers of the Company's products and technology are primarily agencies of the U.S. government. The following table summarizes the percentages of net sales by principal end user:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
U.S. government | 96 | % | | 96 | % | | 96 | % | | |
Non U.S. government customers | 4 | | | 4 | | | 4 | | | |
The following table summarizes the percentages of net sales for significant programs, all of which are included in the U.S. government sales and are comprised of multiple contracts:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
RS-25 program | 17 | % | | 18 | % | | 17 | % | | |
Standard Missile program | 12 | | | 13 | | | 13 | | | |
PAC-3 program | 10 | | | 10 | | | 10 | | | |
THAAD program | 8 | | | 11 | | | 10 | | | |
| | | | | | | |
Major Customers
The following table summarizes the customers that represented more than 10% of net sales, each of which involves sales of several product lines and programs: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
Lockheed Martin | 32 | % | | 34 | % | | 33 | % | | |
| | | | | | | |
| | | | | | | |
NASA | 20 | | | 21 | | | 21 | | | |
Raytheon Technologies Corporation ("Raytheon") | 17 | | | 17 | | | 17 | | | |
| | | | | | | |
United Launch Alliance ("ULA") | * | | * | | 10 | | | |
| | | | | | | |
________
* Less than 10%.
Credit Risk
Aside from investments held in the Company’s retirement benefit plans, financial instruments that could potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and trade receivables. The Company’s cash and cash equivalents are held and managed by recognized financial institutions and are subject to the Company’s investment policy. The investment policy outlines minimum acceptable credit ratings for each type of investment and limits the amount of credit exposure to any one security issue. The Company does not believe significant concentration of credit risk exists with respect to these investments.
The following table summarizes customers that represented more than 10% of accounts receivable, including unbilled receivables which are a component of contract assets: | | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
Raytheon | 26 | % | | 20 | % |
Lockheed Martin | 17 | | | 21 | |
The Boeing Company | 17 | | | 16 | |
ULA | 11 | | | * |
NASA | 10 | | | * |
| | | |
| | | |
________
* Less than 10%.
Dependence on Single Source and Other Third Party Suppliers
The Company uses a significant quantity of raw materials that are highly dependent on market fluctuations and government regulations. Further, as a U.S. government contractor, the Company is often required to procure materials from suppliers capable of meeting rigorous customer and government specifications. As market conditions change for these companies, they often discontinue materials with low sales volumes or profit margins. The Company is often forced to either qualify new materials or pay higher prices to maintain the supply. To date the Company has been successful in establishing replacement materials and securing customer funding to address specific qualification needs of the programs. Prolonged disruptions in the supply of any of the Company’s key raw materials, difficulty qualifying new sources of supply, implementing use of replacement materials or new sources of supply, and/or a continuing volatility in the prices of raw materials could have a material adverse effect on the Company’s operating results, financial condition, and/or cash flows.
Workforce
As of December 31, 2021, 8% of the Company’s employees were covered by collective bargaining agreements.
w. Related Parties
Warren G. Lichtenstein, the Executive Chairman of the Company is also the Executive Chairman of Steel Partners Holdings L.P. ("Steel Holdings") and the Chief Executive Officer of Steel Partners Ltd. ("SPL"). The Company received services of $0.1 million and $1.1 million in 2020, and 2019, respectively, from Steel Holdings and SPL, primarily included administrative services and the use of an aircraft for business travel. As of December 31, 2020, the Company had liabilities due to such entities of $0.1 million.
Lucas-Milhaupt, Inc., an indirect wholly-owned subsidiary of Steel Holdings, sold $0.3 million in raw materials to the Company for the manufacture of its products in 2019.
GAMCO Investors, Inc. ("GAMCO") owned 6% and 8% of the Company's common stock at December 31, 2021 and 2020, respectively. The Company received services of $1.0 million, $0.8 million, and $1.0 million in 2021, 2020, and 2019, respectively, from GAMCO for investment management fees of the Company’s defined benefit pension plan assets.
BlackRock, Inc. ("BlackRock") owned 15% and 15% of the Company's common stock at December 31, 2021 and 2020, respectively. The Company invests in money market funds managed by BlackRock.
The Vanguard Group, Inc. ("Vanguard") owned 10% and 10% of the Company’s common stock at December 31, 2021 and 2020, respectively. Certain of the investment alternatives offered through the Company’s 401(k) plan and grantor trust include funds managed by Vanguard.
x. Accounting Pronouncements
Recently Issued Accounting Pronouncements
In August 2020, the FASB issued guidance which simplifies the accounting for convertible instruments. This guidance eliminates certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, the guidance eliminates certain of the conditions for equity classification for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The Company will adopt the new guidance as of January 1, 2022, using the modified retrospective approach. The adoption of the guidance will result in the reported balance of the 2¼% Notes being the par value offset only by the unamortized debt issuance costs. Further, the adoption of the new guidance will result in the reduction of non-cash interest expense through the maturity of the 2¼% Notes. In 2021, amortization of the debt discount on the 2¼% Notes was $4.3 million.
Note 2. Earnings Per Share
The following table reconciles the numerator and denominator used to calculate basic and diluted EPS: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions, except per share amounts) |
Numerator: | | | | | | | |
| | | | | | | |
| | | | | | | |
Net income | $ | 143.7 | | | $ | 137.7 | | | $ | 141.0 | | | |
Income allocated to participating securities | (0.9) | | | (1.7) | | | (2.6) | | | |
| | | | | | | |
| | | | | | | |
Net income for basic and diluted EPS | $ | 142.8 | | | $ | 136.0 | | | $ | 138.4 | | | |
Denominator: | | | | | | | |
Basic weighted average shares | 79.2 | | | 77.4 | | | 77.2 | | | |
Effect of: | | | | | | | |
21/4% Notes | 2.4 | | | 4.5 | | | 4.4 | | | |
| | | | | | | |
Awards issued under equity plans | 0.1 | | | — | | | 0.1 | | | |
Diluted weighted average shares | 81.7 | | | 81.9 | | | 81.7 | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Basic EPS | $ | 1.80 | | | $ | 1.76 | | | $ | 1.79 | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Diluted EPS | $ | 1.75 | | | $ | 1.66 | | | $ | 1.69 | | | |
Securities which would have been anti-dilutive are insignificant and are excluded from the computation of diluted earnings per share in all periods presented.
Note 3. Balance Sheet Accounts and Supplemental Disclosures
a. Accounts Receivable
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Billed | $ | 60.3 | | | $ | 75.3 | |
| | | |
Other trade receivables | 0.3 | | | 0.3 | |
| | | |
| | | |
| | | |
Accounts receivable | $ | 60.6 | | | $ | 75.6 | |
b. Other Current Assets
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Deferred costs recoverable from the U.S. government | $ | 37.4 | | | $ | 41.0 | |
Income tax receivable | 22.1 | | | 46.9 | |
| | | |
| | | |
Prepaid expenses | 15.3 | | | 18.0 | |
| | | |
| | | |
Inventories | 10.0 | | | 10.0 | |
| | | |
| | | |
Other | 23.0 | | | 20.6 | |
Other current assets | $ | 107.8 | | | $ | 136.5 | |
c. Property, Plant and Equipment, net
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Land | $ | 71.1 | | | $ | 71.2 | |
Buildings and improvements | 503.0 | | | 433.4 | |
Machinery and equipment, including capitalized software | 499.1 | | | 471.3 | |
Construction-in-progress | 50.0 | | | 105.5 | |
| 1,123.2 | | | 1,081.4 | |
Less: accumulated depreciation | (702.1) | | | (658.3) | |
Property, plant and equipment, net | $ | 421.1 | | | $ | 423.1 | |
Depreciation expense for 2021, 2020, and 2019 was $48.8 million, $49.2 million, and $58.1 million, respectively. The Company had $8.8 million of property, plant and equipment additions included in accounts payable as of December 31, 2021.
d. Intangible Assets
| | | | | | | | | | | | | | | | | |
| As of December 31, 2021 |
| Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| (In millions) |
Customer related | $ | 87.2 | | | $ | 81.3 | | | $ | 5.9 | |
Intellectual property\trade secrets | 34.2 | | | 22.3 | | | 11.9 | |
| | | | | |
Trade name | 21.0 | | | 6.1 | | | 14.9 | |
Acquired technology | 19.2 | | | 17.0 | | | 2.2 | |
Intangible assets | $ | 161.6 | | | $ | 126.7 | | | $ | 34.9 | |
| | | | | | | | | | | | | | | | | |
| As of December 31, 2020 |
| Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| (In millions) |
Customer related | $ | 87.2 | | | $ | 75.3 | | | $ | 11.9 | |
Intellectual property\trade secrets | 34.2 | | | 19.7 | | | 14.5 | |
| | | | | |
Trade name | 21.0 | | | 5.4 | | | 15.6 | |
Acquired technology | 19.2 | | | 16.4 | | | 2.8 | |
Intangible assets | $ | 161.6 | | | $ | 116.8 | | | $ | 44.8 | |
The intangible assets relate to the Company’s Aerospace and Defense segment. Amortization expense related to intangible assets was $9.9 million, $13.4 million, and $13.6 million in 2021, 2020, and 2019, respectively.
Future amortization expense for the five succeeding years is estimated to be as follows:
| | | | | |
Year Ending December 31, | Future Amortization Expense |
| (In millions) |
2022 | $ | 6.6 | |
2023 | 6.1 | |
2024 | 4.8 | |
2025 | 3.7 | |
2026 | 2.1 | |
| $ | 23.3 | |
e. Other Noncurrent Assets
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Real estate held for entitlement and leasing | $ | 103.7 | | | $ | 101.8 | |
Receivable from Northrop Grumman Corporation for environmental remediation costs | 34.5 | | | 40.5 | |
| | | |
Deferred costs recoverable from the U.S. government | 62.1 | | | 54.7 | |
| | | |
| | | |
| | | |
| | | |
| | | |
Other | 43.0 | | | 57.8 | |
Other noncurrent assets | $ | 243.3 | | | $ | 254.8 | |
f. Other Current Liabilities
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Accrued compensation and employee benefits | $ | 122.0 | | | $ | 118.0 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Dividends payable | 1.7 | | | 447.8 | |
Other | 49.0 | | | 43.9 | |
Other current liabilities | $ | 172.7 | | | $ | 609.7 | |
g. Accumulated Other Comprehensive Loss, Net of Income Taxes
The following table presents the changes in accumulated other comprehensive loss by components, net of income taxes:
| | | | | | | | | | | | | | | | | |
| Actuarial Losses, Net | | Prior Service Credits (Costs), Net | | Total |
| (In millions) |
| | | | | |
| | | | | |
| | | | | |
December 31, 2019 | $ | (236.4) | | | $ | (0.1) | | | $ | (236.5) | |
Actuarial losses, net of income taxes | (31.5) | | | — | | | (31.5) | |
Amortization of net actuarial losses and prior service credits, net of income taxes | 40.3 | | | 0.1 | | | 40.4 | |
December 31, 2020 | (227.6) | | | — | | | (227.6) | |
Actuarial gains, net of income taxes | 80.5 | | | — | | | 80.5 | |
Amortization of net actuarial losses and prior service costs, net of income taxes | 46.0 | | | 0.1 | | | 46.1 | |
December 31, 2021 | $ | (101.1) | | | $ | 0.1 | | | $ | (101.0) | |
Note 4. Leases
The Company and its subsidiaries lease certain facilities, machinery and equipment, and office buildings under long-term, non-cancelable operating leases. The leases generally provide for renewal options ranging from one to twenty years.
The following table summarizes the Company's lease costs:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2021 | | 2020 | | 2019 |
| (In millions) |
Operating lease cost | $ | 16.0 | | | $ | 15.5 | | | $ | 14.2 | |
Finance lease cost: | | | | | |
Amortization | 2.6 | | | 2.9 | | | 4.0 | |
Interest on lease liabilities | 2.6 | | | 2.7 | | | 2.9 | |
Short-term lease cost | 0.5 | | | 0.5 | | | 0.8 | |
Total lease costs | $ | 21.7 | | | $ | 21.6 | | | $ | 21.9 | |
The following table summarizes the supplemental cash flow information related to leases:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2021 | | 2020 | | 2019 |
| (In millions) |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | |
Operating cash flows for operating leases | $ | 15.6 | | | $ | 13.7 | | | $ | 14.2 | |
Operating cash flows for finance leases | 2.6 | | | 2.7 | | | 2.9 | |
Financing cash flows for finance leases | 2.2 | | | 2.1 | | | 3.3 | |
Assets obtained in exchange for lease obligations: | | | | | |
Operating leases | 36.3 | | | 11.9 | | | 7.7 | |
Finance leases | — | | | — | | | 23.8 | |
The following table summarizes the supplemental balance sheet information related to leases: | | | | | | | | | | | | | | | | | |
| As of December 31, | | | | | | |
| 2021 | | 2020 | | | | |
| (In millions) |
Operating leases: | | | | | | | | | |
Operating lease right-of-use assets | $ | 52.6 | | | $ | 46.8 | | | | | | | |
Operating lease liabilities (component of other current liabilities) | $ | 13.4 | | | $ | 13.4 | | | | | | | |
Operating lease liabilities, noncurrent | 41.3 | | | 35.7 | | | | | | | |
Total operating lease liability | $ | 54.7 | | | $ | 49.1 | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Finance leases: | | | | | | | | | |
Property, plant and equipment | $ | 52.9 | | | $ | 52.9 | | | | | | | |
Accumulated depreciation | (11.3) | | | (8.6) | | | | | | | |
Property, plant and equipment, net | $ | 41.6 | | | $ | 44.3 | | | | | | | |
Current portion of long-term debt | $ | 1.9 | | | $ | 2.2 | | | | | | | |
Long-term debt | 41.5 | | | 43.4 | | | | | | | |
Total finance lease liability | $ | 43.4 | | | $ | 45.6 | | | | | | | |
| | | | | | | | | |
Weighted-average remaining lease term (in years): | | | | | | | | | |
Operating leases | 7 | | 7 | | | | | | |
Finance leases | 16 | | 17 | | | | | | |
Weighted-average discount rate: | | | | | | | | | |
Operating leases | 3.8 | % | | 4.4 | % | | | | | | |
Finance leases | 5.9 | % | | 5.9 | % | | | | | | |
The Company has additional operating leases that have not yet commenced amounting to $0.8 million. These operating leases will commence in 2022 with lease terms of up to one year.
The following table presents the maturities of lease liabilities and lease revenue in effect as of December 31, 2021: | | | | | | | | | | | | | | | | | | | |
Year Ending December 31, | | | Operating Leases | | Finance Leases | | Future Minimum Rental Income |
| | | (In millions) |
2022 | | | $ | 15.2 | | | $ | 4.4 | | | $ | 1.9 | |
2023 | | | 9.5 | | | 3.7 | | | 1.2 | |
2024 | | | 5.5 | | | 3.8 | | | 1.1 | |
2025 | | | 4.8 | | | 3.8 | | | 1.1 | |
2026 | | | 5.0 | | | 3.9 | | | 1.2 | |
Thereafter | | | 22.9 | | | 49.8 | | | 5.5 | |
Total minimum rentals | | | 62.9 | | | 69.4 | | | 12.0 | |
| | | | | | | |
| | | | | | | |
Less: imputed interest | | | (8.2) | | | (26.0) | | | — | |
Total | | | $ | 54.7 | | | $ | 43.4 | | | $ | 12.0 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
The Company also leases certain surplus facilities to third parties. The Company recorded lease income of $2.5 million, $3.3 million, and $7.5 million in 2021, 2020 and 2019, respectively, related to these arrangements, which have been included in net sales.
Note 5. Income Taxes
The Company files a consolidated U.S. federal income tax return with its wholly-owned subsidiaries. The following table presents the components of the Company’s income tax provision: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
Current | | | | | | | |
U.S. federal | $ | 55.0 | | | $ | 4.8 | | | $ | 45.2 | | | |
State and local | 14.3 | | | (0.1) | | | 11.5 | | | |
| 69.3 | | | 4.7 | | | 56.7 | | | |
Deferred | | | | | | | |
U.S. federal | (17.3) | | | 26.1 | | | (8.1) | | | |
State and local | (0.7) | | | 11.7 | | | 2.3 | | | |
| (18.0) | | | 37.8 | | | (5.8) | | | |
Income tax provision | $ | 51.3 | | | $ | 42.5 | | | $ | 50.9 | | | |
The following table presents the reconciling items between the income tax provision using the U.S. federal statutory rate and the Company's reported income tax provision. | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) | | |
Statutory U.S. federal income tax | $ | 41.0 | | | $ | 37.9 | | | $ | 40.3 | | | |
State income taxes, net of federal benefit | 11.9 | | | 9.1 | | | 10.9 | | | |
| | | | | | | |
Reserve adjustments | 0.1 | | | 1.2 | | | 3.9 | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Nondeductible compensation | 1.6 | | | 3.4 | | | 1.0 | | | |
Tax credits and special deductions | 0.6 | | | (4.6) | | | (2.7) | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Convertible debt | (3.4) | | | — | | | — | | | |
Stock-based compensation excess tax benefits | (1.0) | | | (4.4) | | | (2.3) | | | |
Other | 0.5 | | | (0.1) | | | (0.2) | | | |
| | | | | | | |
Income tax provision | $ | 51.3 | | | $ | 42.5 | | | $ | 50.9 | | | |
The following table presents a reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate on earnings in percentages. | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
Statutory U.S. federal income tax rate | 21.0 | % | | 21.0 | % | | 21.0 | % | | |
State income taxes, net of federal benefit | 6.1 | | | 5.1 | | | 5.7 | | | |
| | | | | | | |
Reserve adjustments | — | | | 0.7 | | | 2.0 | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Nondeductible compensation | 0.8 | | | 1.9 | | | 0.5 | | | |
Tax credits and special deductions | 0.3 | | | (2.6) | | | (1.4) | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Convertible debt | (1.8) | | | — | | | — | | | |
Stock-based compensation excess tax benefits | (0.5) | | | (2.4) | | | (1.2) | | | |
Other | 0.4 | | | (0.1) | | | (0.1) | | | |
| | | | | | | |
Effective income tax rate | 26.3 | % | | 23.6 | % | | 26.5 | % | | |
In 2021, the Company’s effective tax rate was 26.3%. The Company's effective tax rate differed from the 21% statutory federal income tax rate primarily due to state income taxes, uncertain tax positions, and certain expenditures which are permanently not deductible for tax purposes, offset by R&D credits, excess tax benefits related to the Company’s stock-based compensation and deductible premiums paid upon the redemption of a portion of the Company’s convertible debt.
In 2020, the Company’s effective tax rate was 23.6%.he Company's effective tax rate differed from the 21% statutory federal income tax rate primarily due to state income taxes, uncertain tax positions, and certain expenditures which are permanently not deductible for tax purposes, offset by R&D credits and excess tax benefits related to the Company's stock-based compensation.
In 2019, the Company’s effective tax rate was 26.5%. The Company’s effective tax rate differed from the 21% statutory federal income tax rate primarily due to state income taxes and uncertain tax positions, offset by R&D credits and excess tax benefits related to the Company’s stock-based compensation.
The Company is routinely examined by domestic tax authorities. While it is difficult to predict the outcome or timing of a particular tax matter, the Company believes it has adequately provided reserves for any reasonable foreseeable outcome related to these matters.
The State of Florida notified the Company they would be opening an income tax audit for the years ended December 31, 2016, through December 31, 2018. The audit began in the first quarter of 2020 and concluded in the third quarter of 2021. The audit resulted in an immaterial favorable adjustment.
U.S. federal tax returns for the years ended December 31, 2018, through December 31, 2020, remain open to examination. Tax returns for the years ended December 31, 2017, through December 31, 2020, remain open to examination for state income tax jurisdictions.
The following table presents a reconciliation of unrecognized tax benefits: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
Balances at beginning of year | $ | 14.2 | | | $ | 58.0 | | | $ | 7.4 | | | |
Increases based on tax positions in prior years | 0.3 | | | 2.7 | | | 40.4 | | | |
Decreases based on tax position in prior years | (0.4) | | | (51.5) | | | — | | | |
Increases based on tax positions in current year | 6.6 | | | 5.6 | | | 10.4 | | | |
Lapse of statute of limitations | (0.7) | | | (0.6) | | | (0.2) | | | |
Balances at end of year | $ | 20.0 | | | $ | 14.2 | | | $ | 58.0 | | | |
As of December 31, 2021, the total amount of unrecognized tax benefits was $20.0 million which would all affect the effective tax rate. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2021, the Company’s accrued interest and penalties related to uncertain tax positions was $0.6 million. It is reasonably possible that a reduction of up to $2.4 million of unrecognized tax benefits and related interest and penalties may occur within the next 12 months as a result of the expiration of certain statutes of limitations.
Deferred Income Taxes
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of the Company’s assets and liabilities for financial reporting and income tax purposes. Deferred tax assets and liabilities are determined by multiplying such differences by the enacted tax rates expected to be in effect when such differences are recovered or settled.
The following table presents the deferred tax assets and liabilities: | | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Deferred Tax Assets | | | |
Accrued estimated costs | $ | 49.5 | | | $ | 48.4 | |
Basis difference in assets and liabilities | 58.8 | | | 68.5 | |
Operating lease liabilities | 13.7 | | | 12.3 | |
Tax losses and credit carryforwards | 0.4 | | | 1.7 | |
Net cumulative defined benefit pension plan losses | 58.8 | | | 81.5 | |
Retiree medical and life insurance benefits | 4.7 | | | 6.0 | |
| | | |
Total deferred tax assets | 185.9 | | | 218.4 | |
Deferred Tax Liabilities | | | |
Revenue recognition differences | 104.8 | | | 116.7 | |
Basis differences in intangible assets | 10.7 | | | 9.2 | |
ROU assets | 12.9 | | | 11.4 | |
Total deferred tax liabilities | 128.4 | | | 137.3 | |
Total net deferred tax assets | $ | 57.5 | | | $ | 81.1 | |
Realization of deferred tax assets is primarily dependent on generating sufficient taxable income in future periods. The Company believes it is more likely than not its deferred tax assets will be realized. Accordingly, no valuation allowance was recorded for 2021 and 2020.
The Company fully utilized its federal net operating loss carryforwards and income tax credits in 2018. The Company utilized substantially all of its state net operating loss carryforwards in 2019. The Company’s California income tax credit carryovers have been fully utilized as of December 31, 2021.
Note 6. Long-Term Debt
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Senior debt | $ | 281.4 | | | $ | 307.1 | |
| | | |
Convertible senior notes | 136.5 | | | 271.6 | |
| | | |
Finance leases (see Note 4) | 43.4 | | | 45.6 | |
Total debt, carrying amount | 461.3 | | | 624.3 | |
Less: Amounts due within one year | (166.7) | | | (299.9) | |
Total long-term debt, carrying amount | $ | 294.6 | | | $ | 324.4 | |
The following table presents as of December 31, 2021, the earlier of the Company’s contractual debt principal maturities excluding finance lease obligations (see Note 4): | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Total | | | | 2022 | | 2023 | | | | | | | |
| (In millions) |
Senior debt | $ | 282.2 | | | | | $ | 28.4 | | | $ | 253.8 | | | | | | | | |
| | | | | | | | | | | | | | |
Convertible senior notes | 145.9 | | | | | 145.9 | | | — | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| $ | 428.1 | | | | | $ | 174.3 | | | $ | 253.8 | | | | | | | | |
The Company amortizes deferred financing costs over the estimated life of the related debt (a portion of which is classified as a contra liability). Amortization of deferred financing costs was $1.6 million, $2.0 million, and $1.9 million in 2021, 2020, and 2019, respectively.
a. Senior Debt
| | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Term loan, bearing interest at variable rates (rate of 1.85% as of December 31, 2021), maturing in September 2023 | $ | 282.2 | | | $ | 308.5 | |
| | | |
Unamortized deferred financing costs | (0.8) | | | (1.4) | |
Total senior debt | $ | 281.4 | | | $ | 307.1 | |
The senior secured senior credit facility (the "Senior Credit Facility") matures on September 20, 2023, and consists of (i) a $650.0 million revolving line of credit (the "Revolver") and (ii) a $350.0 million term loan (the "Term Loan").
As of December 31, 2021, the Company had zero borrowings under the Revolver and had issued $27.8 million letters of credit.
The Term Loan and any borrowings under the Revolver bear interest at LIBOR plus an applicable margin ranging from 175 to 250 basis points based on the Company's leverage ratio (the "Consolidated Net Leverage Ratio") measured at the end of each quarter. In addition to interest, the Company must pay certain fees including (i) letter of credit fees ranging from 175 to 250 basis points per annum on the amount of issued but undrawn letters of credit and eurocurrency rate loans and (ii) commitment fees ranging from 30 to 45 basis points per annum on the unused portion of the Revolver.
The Term Loan amortized at a rate of 7.5% per annum as of December 31, 2021, and increasing to 10.0% per annum from December 31, 2022, to be paid in equal quarterly installments with any remaining amounts, along with outstanding borrowings under the Revolver, due on the maturity date. Outstanding borrowings under the Revolver and the Term Loan may be voluntarily repaid at any time, in whole or in part, without premium or penalty.
The Senior Credit Facility is secured by a first priority security interest in the Company’s assets, subject to certain customary exceptions, as well as pledges of its equity interests in certain subsidiaries.
The Senior Credit Facility contains financial covenants requiring the Company to (i) maintain an interest coverage ratio (the "Consolidated Interest Coverage Ratio") of not less than 3.00 to 1.00 and (ii) maintain a Consolidated Net Leverage Ratio not to exceed 3.50 to 1.00 provided that the maximum leverage ratio for all periods shall be increased by 0.50 to 1.00 for two consecutive quarters after consummation of a qualified acquisition.
The Company may generally make certain investments, redeem debt subordinated to the Senior Credit Facility and make certain restricted payments (such as stock repurchases and dividends) if the Company's Consolidated Net Leverage Ratio does not exceed 3.25 to 1.00 pro forma for such transaction. The Company is otherwise subject to customary covenants including limitations on asset sales, incurrence of additional debt, and limitations on certain investments and restricted payments.
The Company was in compliance with its financial and non-financial covenants as of December 31, 2021.
b. Convertible Senior Notes | | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
| (In millions) |
Senior convertible notes, bearing interest at 2.25% per annum, interest payments due in June and December, maturing in December 2023 | $ | 145.9 | | | $ | 300.0 | |
Unamortized discount and deferred financing costs | (9.4) | | | (28.4) | |
Total convertible senior notes | $ | 136.5 | | | $ | 271.6 | |
On December 14, 2016, the Company issued $300.0 million aggregate principal amount of 2¼% Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The 2¼% Notes bear cash interest at a rate of 2.25% per annum on the principal amount of the 2¼% Notes from December 14, 2016, payable semi-annually in arrears on June 15 and December 15 of each year, beginning June 15, 2017. The 2¼% Notes will mature on December 15, 2023, subject to earlier repurchase, redemption or conversion in certain circumstances described below.
In 2021, the Company settled $154.1 million of its 2¼% Notes. The principal amount was settled in cash and the conversion premium was settled in common shares. See Note 11.
The 2¼% Notes are general unsecured senior obligations, which (i) rank senior in right of payment to all of the Company’s existing and future senior indebtedness that is expressly subordinated in right of payment to the 2¼% Notes; (ii) rank equal in right of payment with all of the Company’s existing and future unsecured indebtedness that is not so subordinated; (iii) rank effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and (iv) rank structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries.
The 2¼% Notes may be converted into cash, shares of the Company’s common stock or a combination thereof initially at a conversion rate of 38.4615 shares of common stock per $1,000 principal amount of 2¼% Notes (equivalent to a conversion price of approximately $26.00 per share of common stock), subject to adjustment from time to time as described in the indenture governing the 2¼% Notes. Holders may convert their 2¼% Notes at their option (i) at any time prior to the close of business on the business day immediately preceding September 15, 2023, under certain circumstances and (ii) at any time on or after September 15, 2023, until the close of business on the business day immediately preceding the maturity date, irrespective of such circumstances. In addition, if holders of the 2¼% Notes elect to convert their 2¼% Notes in connection with the occurrence of a make-whole fundamental change, as defined in the indenture governing the 2¼% Notes, such holders will be entitled to an increase in the conversion rate upon conversion in certain circumstances.
Holders may convert their 2¼% Notes at their option from January 1, 2022, through March 31, 2022, because the Company's closing stock price exceeded $33.80 for at least 20 days in the 30 day period prior to December 31, 2021. The Company has a stated intention to cash settle the principal amount of the 2¼% Notes with the conversion premium to be settled in common shares. Accordingly, the net balance of the 2¼% Notes of $136.5 million is classified as a current liability as of December 31, 2021.
As more fully described in the indenture governing the 2¼% Notes, the holders of the 2¼% Notes may surrender all or any portion of their 2¼% Notes for conversion at any time during any calendar quarter, (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% ($33.80) of the conversion price on each applicable trading day.
The Company may redeem for cash all or any portion of the 2¼% Notes, at its option, on or after December 21, 2020, if the last reported sale price of the Company’s common stock has been at least 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2¼% Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.
If a fundamental change, as defined in the indenture governing the 2¼% Notes, occurs prior to maturity, subject to certain conditions, holders of the 2¼% Notes will have the right to require the Company to repurchase all or part of their 2¼% Notes for cash at a fundamental change repurchase price equal to 100% of their principal amount, plus accrued and unpaid interest, if any, up to, but excluding, the fundamental change repurchase date.
The 2¼% Notes contain customary events of default, including, among other things, payment default, covenant default and certain cross-default provisions linked to the payment of other indebtedness of the Company or its significant subsidiaries.
Issuance of the 2¼% Notes generated proceeds of $294.2 million net of debt issuance costs, which were used to repurchase long-term debt and for working capital and other general corporate purposes.
On December 19, 2020, the Company's Board of Directors declared the one-time Pre-Closing Dividend in cash of $5.00 per share (including shares underlying the 2¼% Notes participating on an as-converted basis). See Note 1 for additional information.
The Company separately accounted for the liability and equity components of the 2¼% Notes. The initial liability component of the 2¼% Notes was valued based on the present value of the future cash flows using an estimated borrowing rate at the date of the issuance for similar debt instruments without the conversion feature, which equals the effective interest rate of 5.8% on the liability component. The equity component, or debt discount, was initially valued equal to the principal value of the 2¼% Notes, less the liability component. The debt discount is being amortized as a non-cash charge to interest expense over the period from the issuance date through December 15, 2023.
The debt issuance costs of $5.8 million incurred in connection with the issuance of the 2¼% Notes were capitalized and bifurcated into deferred financing costs of $4.7 million and equity issuance costs of $1.1 million. The deferred financing costs are being amortized to interest expense from the issuance date through December 15, 2023.
The following table summarizes the 2¼% Notes information (in millions, except years, percentages, conversion rate, and conversion price): | | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
Carrying value | $ | 136.5 | | | $ | 271.6 | |
Unamortized discount and deferred financing costs | 9.4 | | | 28.4 | |
Principal amount | $ | 145.9 | | | $ | 300.0 | |
Carrying amount of equity component, net of equity issuance costs | $ | — | | | $ | 54.5 | |
Remaining amortization period (years) | 2.0 | | 3.0 |
Effective interest rate | 5.8 | % | | 5.8 | % |
Conversion rate (shares of common stock per $1,000 principal amount) | 38.4615 | | 38.4615 |
Conversion price (per share of common stock) | $ | 26.00 | | | $ | 26.00 | |
Based on the Company's closing stock price of $46.76 on December 31, 2021, the if-converted value of the 2¼% Notes exceeded the aggregate principal amount of the 2¼% Notes by $116.5 million.
The following table presents the interest expense components for the 2¼% Notes: | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2021 | | 2020 | | 2019 |
| (In millions) |
Interest expense-contractual interest | $ | 3.3 | | | $ | 6.8 | | | $ | 6.8 | |
Interest expense-amortization of debt discount | 4.3 | | | 7.9 | | | 7.5 | |
Interest expense-amortization of deferred financing costs | 0.4 | | | 0.6 | | | 0.6 | |
Note 7. Retirement Benefits
a. Plan Descriptions
Pension Benefits
The Company's defined benefit pension plan future benefit accrual was discontinued in 2009. As of December 31, 2021, the assets, projected benefit obligations, and unfunded pension obligation were $1,005.0 million, $1,279.3 million, and $274.3 million, respectively.
The American Rescue Plan Act of 2021 ("ARPA") that was signed into law on March 11, 2021, provided funding relief to sponsors of defined benefit pension plans. In line with provisions of ARPA, the Company expects to make cash contributions of approximately $15 million to its tax-qualified defined benefit pension plan in 2022. The Company is generally able to recover contributions related to its tax-qualified defined benefit pension plan as allowable costs on its U.S. government contracts, but there are differences between when the Company contributes to its tax-qualified defined benefit pension plan under pension funding rules and when it is recoverable under Cost Accounting Standards ("CAS"). The Company estimates the CAS recoverable amounts related to the Company's retirement benefits plans to be approximately $38 million in 2022. During 2021, the Company made cash contributions of $17.3 million and used $20.0 million of prepayment credits to fund its tax-qualified defined benefit pension plan.
The funded status of the Company's tax-qualified pension plan may be adversely affected by the investment experience of the plan's assets, by any changes in U.S. law and by changes in the statutory interest rates used by tax-qualified pension plans in the U.S. to calculate funding requirements. Accordingly, if the performance of the plan's assets does not meet assumptions, if there are changes to income tax regulations or other applicable law, or if other actuarial assumptions are modified, future contributions to the underfunded pension plans could be higher than the Company expects.
Medical and Life Insurance Benefits
The Company provides medical and life insurance benefits to certain eligible retired employees, with varied coverage by employee group. Generally, employees hired after January 1, 1997, are not eligible for retiree medical and life insurance benefits. The medical benefit plan provides for cost sharing between the Company and its retirees in the form of retiree contributions, deductibles, and coinsurance. Medical and life insurance benefit obligations are unfunded. Medical and life insurance benefit cash payments for eligible retired employees are recoverable from the Company’s U.S. government contracts.
Defined Contribution 401(k) Benefits
The Company sponsors a defined contribution 401(k) plan and participation in the plan is available to all employees. The Company makes matching contributions in cash equal to 100% of the first 3% of the participants’ compensation contributed and 50% of the next 3% of the compensation contributed. The cost of the 401(k) plan was $22.8 million, $21.8 million, and $21.4 million in 2021, 2020, and 2019, respectively.
b. Plan Results
The following table summarizes the balance sheet impact of the Company’s pension benefits and medical and life insurance benefits. Pension benefits include the consolidated tax-qualified plan and the unfunded non-qualified plan for benefits provided to employees beyond those provided by the Company’s tax-qualified plan. Assets, benefit obligations, and the funded status of the plans were determined at December 31, 2021 and 2020.
| | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Medical and Life Insurance Benefits |
| As of December 31, |
| 2021 | | 2020 | | 2021 | | 2020 |
| (In millions) |
Change in fair value of assets: | | | | | | | |
Fair value - beginning of year | $ | 957.0 | | | $ | 932.5 | | | $ | — | | | $ | — | |
Gain on assets | 135.7 | | | 117.1 | | | — | | | — | |
Employer contributions | 18.8 | | | 15.6 | | | 2.4 | | | 2.8 | |
Benefits paid (1) | (106.5) | | | (108.2) | | | (2.4) | | | (2.8) | |
| | | | | | | |
Fair value - end of year | $ | 1,005.0 | | | $ | 957.0 | | | $ | — | | | $ | — | |
Change in benefit obligation: | | | | | | | |
Benefit obligation - beginning of year | $ | 1,381.5 | | | $ | 1,349.8 | | | $ | 25.0 | | | $ | 25.9 | |
| | | | | | | |
Interest cost | 33.5 | | | 42.5 | | | 0.5 | | | 0.8 | |
| | | | | | | |
Actuarial (gains) losses | (29.2) | | | 97.4 | | | (3.5) | | | 1.1 | |
Benefits paid | (106.5) | | | (108.2) | | | (2.4) | | | (2.8) | |
| | | | | | | |
Benefit obligation and accumulated benefit obligation - end of year | $ | 1,279.3 | | | $ | 1,381.5 | | | $ | 19.6 | | | $ | 25.0 | |
Funded status of the plans | $ | (274.3) | | | $ | (424.5) | | | $ | (19.6) | | | $ | (25.0) | |
Amounts recognized in the consolidated balance sheets: | | | | | | | |
Postretirement medical and life insurance benefits, current | $ | — | | | $ | — | | | $ | (2.7) | | | $ | (3.5) | |
Postretirement medical and life insurance benefits, noncurrent | — | | | — | | | (16.9) | | | (21.5) | |
Pension liability, non-qualified current (component of other current liabilities) | (1.4) | | | (1.3) | | | — | | | — | |
Pension liability, non-qualified (component of other noncurrent liabilities) | (17.0) | | | (18.0) | | | — | | | — | |
Pension benefits, noncurrent | (255.9) | | | (405.2) | | | — | | | — | |
Net liability recognized in the consolidated balance sheets | $ | (274.3) | | | $ | (424.5) | | | $ | (19.6) | | | $ | (25.0) | |
______
(1)Benefits paid for medical and life insurance benefits are net of the Medicare Part D Subsidy of less than $0.1 million, and $0.1 million received in 2021 and 2020, respectively.
The pension benefits obligation actuarial gains of $29.2 million in 2021 were primarily the result of an increase in the discount rate used to determine the obligation. The discount rate was 2.90% as of December 31, 2021, compared with 2.52% as of December 31, 2020. The pension obligation actuarial losses of $97.4 million in 2020 were primarily the result of a decrease in the discount rate used to determine the obligation due to lower market interest rates. The discount rate was 2.52% as of December 31, 2020, compared with 3.28% as of December 31, 2019.
The following table presents the components of retirement benefits expense (income):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Medical and Life Insurance Benefits |
| Year Ended December 31, | | | | Year Ended December 31, | | |
| | | | | | | | | | | | | | | |
| 2021 | | 2020 | | 2019 | | | | 2021 | | 2020 | | 2019 | | |
| (In millions) |
| | | | | | | | | | | | | | | |
Interest cost on benefit obligation | $ | 33.5 | | | $ | 42.5 | | | $ | 52.7 | | | | | $ | 0.5 | | | $ | 0.8 | | | $ | 1.2 | | | |
Assumed return on assets | (61.4) | | | (60.5) | | | (64.8) | | | | | — | | | — | | | — | | | |
Amortization of prior service costs (credits) | 0.1 | | | 0.1 | | | 0.1 | | | | | — | | | — | | | (0.2) | | | |
Amortization of net losses (gains) | 63.9 | | | 57.4 | | | 40.9 | | | | | (2.7) | | | (3.7) | | | (3.8) | | | |
| $ | 36.1 | | | $ | 39.5 | | | $ | 28.9 | | | | | $ | (2.2) | | | $ | (2.9) | | | $ | (2.8) | | | |
The following table presents the actual return and rate of return on assets:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions, except rate of return) |
Actual gain on assets | $ | 135.7 | | | $ | 117.1 | | | $ | 144.8 | | | |
Actual rate of return on assets | 15.0 | % | | 15.6 | % | | 18.0 | % | | |
Market conditions and interest rates significantly affect assets and liabilities of the pension plans. Pension accounting permits market gains and losses to be deferred and recognized over a period of years. This "smoothing" results in the creation of other accumulated income or loss which will be amortized to pension costs in future years. The accounting method the Company utilizes recognizes one-fifth of the unamortized gains and losses in the market-related value of pension assets and all other gains and losses including changes in the discount rate used to calculate the benefit obligation each year. Investment gains or losses for this purpose are the difference between the expected return and the actual return on the market-related value of assets which smoothes asset values over three years. Although the smoothing period mitigates some volatility in the calculation of annual retirement benefits expense, future expenses are impacted by changes in the market value of assets and changes in interest rates.
c. Plan Assumptions
The following table presents the assumptions, calculated based on a weighted-average, to determine the benefit obligations:
| | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Medical and Life Insurance Benefits |
| As of December 31, | | As of December 31, |
| 2021 | | 2020 | | 2021 | | 2020 |
Discount rate | 2.90 | % | | 2.52 | % | | 2.77 | % | | 2.28 | % |
Discount rate (non-qualified plan) | 2.89 | % | | 2.51 | % | | * | | * |
Ultimate healthcare trend rate | * | | * | | 4.50 | % | | 4.50 | % |
Initial healthcare trend rate (pre 65/post 65) | * | | * | | 6.25 | % | | 6.50 | % |
Year ultimate rate attained (pre 65/post 65) | * | | * | | 2029 | | 2028 |
______
* Not applicable
The following table presents the assumptions, calculated based on a weighted-average, to determine the retirement benefits expense (income):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Medical and Life Insurance Benefits |
| Year Ended December 31, | | | | Year Ended December 31, | | |
| | | | | | | | | | | | | | | |
| 2021 | | 2020 | | 2019 | | | | 2021 | | 2020 | | 2019 | | |
Discount rate | 2.52 | % | | 3.28 % | | 4.27 | % | | | | 2.28 | % | | 3.19 % | | 4.09 | % | | |
Discount rate (non-qualified plan) | 2.51 | % | | 3.30 % | | 4.27 | % | | | | * | | * | | * | | |
Expected long-term rate of return on assets | 7.00 | % | | 7.00 % | | 7.00 | % | | | | * | | * | | * | | |
Ultimate healthcare trend rate | * | | * | | * | | | | 4.50 | % | | 4.50 % | | 4.50 | % | | |
Initial healthcare trend rate (pre 65/post 65) | * | | * | | * | | | | 6.50 | % | | 5.50 % | | 6.00 | % | | |
Year ultimate rate attained (pre 65/post 65) | * | | * | | * | | | | 2028 | | 2022 | | 2022 | | |
______
* Not applicable
Certain actuarial assumptions, such as assumed discount rate, long-term rate of return, and assumed healthcare cost trend rates can have a significant effect on amounts reported for periodic cost of pension benefits and medical and life insurance benefits, as well as respective benefit obligation amounts. The assumed discount rate represents the market rate available for investments in high-quality fixed income instruments with maturities matched to the expected benefit payments for pension and medical and life insurance benefit plans.
The expected long-term rate of return on assets represents the rate of earnings expected in the funds invested, and funds to be invested, to provide for anticipated benefit payments to plan participants. The Company evaluated historical investment performance, current and expected asset allocation, and, with input from the Company’s external advisors, developed best estimates of future investment performance. Based on this analysis, the Company assumed a long-term expected rate of return of 7.0% in 2021.
The Company reviews external data and its own historical trends for healthcare costs to determine the healthcare cost trend rates for the medical benefit plans. For 2021 medical benefit obligations, the Company assumed a 6.25% annual rate of increase for pre and post 65 participants in the per capita cost of covered healthcare claims with the rate decreasing over seven years until reaching 4.5%.
d. Plan Assets and Investment Policy
The Company’s investment policy is to maximize the total rate of return within a prudent risk framework, while maintaining adequate liquidity throughout volatile market cycles to meet benefit obligations when due. The Company's strategies employ active management and are generally focused on minimizing the permanent loss of capital. The Company's asset diversification objectives target a diversified portfolio that invests across the capital structure via strategies with complimentary risk and return profiles. Diversification is achieved by investing in various asset types, which may include cash, fixed income, equities, private assets, credit holdings, and future contracts. Further, the Company's strategy allows for diversification as to the types of investment vehicle structures, investment and redemption periods, and the number of investment managers used to carry out its strategy. Allocations between asset types, structures and managers may change as a result of changing market conditions, tactical investment opportunities, planned Company contributions, and cash obligations of the plan.
The following table presents the asset allocations by asset category: | | | | | | | | | | | |
| As of December 31, |
| 2021 | | 2020 |
Cash and cash equivalents | 5 | % | | 2 | % |
Equity securities | 47 | | | 46 | |
Fixed income | 12 | | | 15 | |
Registered investment companies | 1 | | | 2 | |
Private assets | 10 | | | 11 | |
Hedge funds | 25 | | | 24 | |
Total | 100 | % | | 100 | % |
The following tables present the fair value by asset category and by level:
| | | | | | | | | | | | | | | | | | | | | | | |
| Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Other Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| (In millions) |
December 31, 2021 | | | | | | | |
Cash and cash equivalents | $ | 0.1 | | | $ | 0.1 | | | $ | — | | | $ | — | |
Equity securities: | | | | | | | |
Domestic equity securities | 428.5 | | | 428.5 | | | — | | | — | |
International equity securities | 44.2 | | | 44.2 | | | — | | | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Fixed income: | | | | | | | |
Corporate debt securities | 57.5 | | | — | | | 39.9 | | | 17.6 | |
Asset-backed securities | 29.3 | | | — | | | 29.3 | | | — | |
U.S. government securities | 28.8 | | | — | | | 28.8 | | | — | |
Foreign bonds | 0.9 | | | — | | | 0.9 | | | — | |
Derivatives | 0.1 | | | — | | | 0.1 | | | — | |
| | | | | | | |
Registered investment companies | 13.9 | | | 13.9 | | | — | | | — | |
Private assets | 1.2 | | | — | | | — | | | 1.2 | |
Total | 604.5 | | | $ | 486.7 | | | $ | 99.0 | | | $ | 18.8 | |
Investment measured at Net Asset Value ("NAV") | | | | | | | |
Private assets | 97.8 | | | | | | | |
Hedge funds | 254.5 | | | | | | | |
Common/collective trusts ("CCTs") | 56.4 | | | | | | | |
Total investments measured at NAV | 408.7 | | | | | | | |
Receivables | 9.5 | | | | | | | |
Payables | (17.7) | | | | | | | |
Total assets | $ | 1,005.0 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Other Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| (In millions) |
December 31, 2020 | | | | | | | |
Cash and cash equivalents | $ | 0.4 | | | $ | 0.4 | | | $ | — | | | $ | — | |
Equity securities: | | | | | | | |
Domestic equity securities | 406.3 | | | 400.2 | | | — | | | 6.1 | |
International equity securities | 37.0 | | | 37.0 | | | — | | | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Fixed income: | | | | | | | |
Corporate debt securities | 71.5 | | | — | | | 39.6 | | | 31.9 | |
Asset-backed securities | 28.7 | | | — | | | 28.7 | | | — | |
U.S. government securities | 41.4 | | | — | | | 41.4 | | | — | |
Municipal bonds | 0.6 | | | — | | | 0.6 | | | — | |
Foreign bonds | 0.5 | | | — | | | 0.5 | | | — | |
Registered investment companies | 16.4 | | | 16.4 | | | — | | | — | |
Private assets | 3.1 | | | — | | | — | | | 3.1 | |
Total | 605.9 | | | $ | 454.0 | | | $ | 110.8 | | | $ | 41.1 | |
Investment measured at NAV | | | | | | | |
Private assets | 100.8 | | | | | | | |
Hedge funds | 232.3 | | | | | | | |
CCTs | 36.2 | | | | | | | |
Total investments measured at NAV | 369.3 | | | | | | | |
Receivables | 0.9 | | | | | | | |
Payables | (19.1) | | | | | | | |
Total assets | $ | 957.0 | | | | | | | |
Below is a description of the significant investment strategies and valuation methodologies used for the investments measured at fair value, including the general classification of such investments pursuant to the valuation hierarchy. There have been no changes in the methodologies used at December 31, 2021 and 2020.
Cash and cash equivalents
Cash and cash equivalents are invested in money market funds or Short-Term Investment Funds ("STIFs"). Cash and cash equivalents invested in money market funds are classified as Level 1 investments. STIFs are measured at NAV and included in CCTs as a reconciling item to the fair value tables above.
Equity securities
Equity securities are invested broadly in U.S. and non-U.S. companies in a variety of sectors and market capitalizations. These investments are comprised of common stocks, CCTs, and other investment vehicles. Common stocks are stated at fair value as quoted on a recognized securities exchange and are valued at the last reported sales price on the last business day of the year and are classified as Level 1 investments. Equity securities that are invested in common stock of private companies and priced using unobservable inputs are classified as Level 3 investments. CCTs invested in equity securities are measured at NAV and included as a reconciling item to the fair value tables above.
Fixed income securities
Fixed income securities are invested in a variety of instruments, including, but not limited to, corporate debt securities, U.S. government securities, CCTs, asset-backed securities, municipal bonds, foreign bonds, and other investment vehicles. Corporate debt securities are invested in corporate bonds and term loans. Corporate bonds are valued at bid evaluations using observable and market-based inputs and are classified as Level 2 investments. Term loans are priced using unobservable inputs and are classified as Level 3 investments. Asset-backed securities, including government-backed mortgage securities, commercial mortgage-backed securities, auto receivable backed securities, and other asset-backed securities, are valued at bid evaluations and are classified as Level 2 investments. Municipal bonds are valued using pricing models maximizing the use of observable inputs for similar securities and are classified as Level 2 investments. Foreign bonds that are valued using pricing models maximizing the use of observable inputs for similar securities are classified as Level 2 investments. Foreign bonds that are priced using unobservable inputs are classified as Level 3 investments. The foreign bond classified as Level 3 investment had no value at both December 31, 2021 and 2020. CCTs invested in fixed income securities are measured at NAV and included as a reconciling item to the fair value tables above.
Registered investment companies
Registered investment companies are invested in corporate bonds, senior secured loans, and other fixed income. Registered investment companies are transacted at NAV published daily and are classified as Level 1 investments.
Private assets
Private assets are primarily limited partnerships that mainly invest in U.S. and non-U.S. leveraged buyout, venture capital and special situation strategies. Generally, the individual investments within the partnerships or funds are valued at public market, private market, or appraised value. Private assets are valued by investment managers using unobservable inputs such as extrapolated data, proprietary data, or indicative quotes. The majority of the private assets are valued at NAV and included as a reconciling item to the fair value tables above. Private assets for which there is no NAV are classified as Level 3 investments. Valuations of certain assets were based on the NAV or market value three months prior to the year-end. The Company made adjustments amounting to an increase of $1.1 million for 2021 and a decrease of $6.2 million for 2020 to account for changes since the valuation date.
Hedge funds
Hedge funds primarily consist of multi-strategy hedge funds that invest across a range of equity and debt securities in a variety of industry sectors. Hedge funds are valued at NAV calculated by investment managers using unobservable inputs such as extrapolated data, proprietary data, or indicative quotes and are included as a reconciling item to the fair value tables above.
The following tables present the changes in the fair value of the Level 3 investments:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2020 | | Unrealized Gains (Losses) | | Realized Gains | | Purchases, Sales, and Settlements, net | | | | December 31, 2021 |
| (In millions) |
| | | | | | | | | | | |
Equity securities | $ | 6.1 | | | $ | 10.1 | | | $ | 1.1 | | | $ | (17.3) | | | | | $ | — | |
| | | | | | | | | | | |
Corporate debt securities | 31.9 | | | 0.1 | | | — | | | (14.4) | | | | | 17.6 | |
| | | | | | | | | | | |
Private assets | 3.1 | | | — | | | — | | | (1.9) | | | | | 1.2 | |
Total | $ | 41.1 | | | $ | 10.2 | | | $ | 1.1 | | | $ | (33.6) | | | | | $ | 18.8 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2019 | | Unrealized Gains | | Realized Gains | | Purchases, Sales, and Settlements, net | | | | December 31, 2020 |
| (In millions) |
| | | | | | | | | | | |
Equity securities | $ | 4.2 | | | $ | 1.9 | | | $ | — | | | $ | — | | | | | $ | 6.1 | |
| | | | | | | | | | | |
Corporate debt securities | 27.6 | | | 5.4 | | | — | | | (1.1) | | | | | 31.9 | |
| | | | | | | | | | | |
Private assets | 5.4 | | | 1.7 | | | 1.3 | | | (5.3) | | | | | 3.1 | |
Total | $ | 37.2 | | | $ | 9.0 | | | $ | 1.3 | | | $ | (6.4) | | | | | $ | 41.1 | |
e. Benefit Payments
The following table presents estimated future benefit payments:
| | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefit Payments | | Medical and Life Insurance Benefits |
Year Ending December 31, | | Gross Benefit Payments | | Medicare D Subsidy | | Net Benefit Payments |
| (In millions) |
2022 | $ | 104.7 | | | $ | 2.8 | | | $ | 0.1 | | | $ | 2.7 | |
2023 | 101.5 | | | 2.5 | | | 0.1 | | | 2.4 | |
2024 | 98.1 | | | 2.2 | | | 0.1 | | | 2.1 | |
2025 | 94.5 | | | 2.0 | | | 0.1 | | | 1.9 | |
2026 | 90.7 | | | 1.7 | | | — | | | 1.7 | |
Years 2027 - 2031 | 395.1 | | | 6.1 | | | 0.1 | | | 6.0 | |
Note 8. Commitments and Contingencies
a. Legal Matters
The Company and its subsidiaries are subject to legal proceedings, including litigation in U.S. federal and state courts, which arise out of, and are incidental to, the ordinary course of the Company’s on-going and historical businesses. The Company is also subject from time to time to governmental investigations by federal and state agencies. The Company cannot predict the outcome of such proceedings with any degree of certainty. Loss contingency provisions are recorded for probable losses at management’s best estimate of a loss. When only a range of amounts can be reasonably estimated and no amount within the range is more likely than another, the low end of the range is recorded. These estimates are often initially developed substantially earlier than when the ultimate loss is known, and are refined each quarterly reporting period as additional information becomes available.
Merger-Related Litigation
FTC Litigation
On January 25, 2022, the U.S. Federal Trade Commission filed a complaint against Lockheed Martin and the Company in the FTC’s administrative court pursuant to Part 3 of the Federal Trade Commission Act. The FTC also filed a complaint in the U.S. District Court for the District of Columbia ("DDC") seeking a Preliminary Injunction to stop the deal pending an administrative trial, which was scheduled to begin on June 16, 2022. The FTC’s administrative complaint alleged that the Merger Agreement constituted an unfair method of competition in violation of Section 5 of the Federal Trade Commission Act and both the administrative complaint and the DDC complaint alleged that the Merger, if consummated, would have substantially lessened competition in relevant markets in violation of Section 7 of the Clayton Act. The administrative complaint sought the following remedies: if the Merger was consummated, divestiture or reconstitution of all associated and necessary assets, in a manner that restores competition in relevant markets; a prohibition against any transaction between the Company and Lockheed Martin that combined the businesses in relevant markets except as approved by the FTC; a requirement that, for a period of time, the Company and Lockheed Martin provide prior notice to the FTC of acquisitions, mergers, consolidations, or any other combinations of their businesses in relevant markets; a requirement to file periodic compliance reports with the FTC; and any other relief appropriate to correct or remedy the anticompetitive effects of the transaction or to restore the Company as a viable, independent competitor in the relevant markets. The Merger Agreement provided that Lockheed Martin could elect to defend against the FTC Litigation within 30 days of the filing of the litigation or terminate the Merger Agreement. On February 13, 2022, Lockheed Martin notified the Company that it had elected to terminate the Merger Agreement. On February 14, 2022, pursuant to the parties’ joint motion, the administrative complaint and DDC complaint were dismissed.
Shareholder Litigation
As previously disclosed, various lawsuits were filed in the first quarter of 2021 against the Company and members of the Company’s Board of Directors (collectively referred to as the "Actions") alleging that the defendants violated Sections 14(a) (and Rule 14a-9 promulgated thereunder) and 20(a) of the Exchange Act by, among other things, omitting certain allegedly material information with respect to the Merger in the preliminary proxy statement filed by the Company on January 25, 2021, and/or the definitive proxy statement filed by the Company on February 5, 2021, and, in the case of three of the Actions, alleging breaches of fiduciary duties in connection with the Merger. In April 2021, following the Company’s filing of additional definitive proxy soliciting materials and its agreement to pay an immaterial amount to cover plaintiffs’ attorneys’ fees and expenses, the plaintiffs in each of the Actions voluntarily dismissed their lawsuits. No assurance can be given that additional lawsuits will not be filed against the Company and/or its directors and officers in connection with the Merger.
Proxy Contest Litigation
Lichtenstein, Henderson, McNiff and Turchin Complaint
On February 7, 2022, Warren G. Lichtenstein, James R. Henderson, Audrey A. McNiff and Martin Turchin (the "LHMT Plaintiffs") filed suit in the Court of Chancery of the State of Delaware seeking, among other things, declaratory relief relating to SPH Group Holdings LLC’s (“SPH”) nomination of the LHMT Plaintiffs and its other nominees for election to the Board of Directors of the Company, a nominal party to the lawsuit, at its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). The LHMT Plaintiffs filed the lawsuit due to disagreements among the Company’s evenly divided eight-member Board, which consists of the four LHMT Plaintiffs and four other directors – Eileen P. Drake, Thomas Corcoran, General Kevin P. Chilton USAF (Ret.) and General Lance W. Lord, USAF (Ret.) (the "CCDL Defendants"), over matters relating to Steel Holdings’ nomination and the Annual Meeting. As enumerated in the lawsuit, the LHMT Plaintiffs seek the following relief:
•A declaration that no Aerojet officer, director, employee or anyone else acting or purporting to act on the Company’s behalf may speak on behalf of the Company or take any action on behalf of the Company without proper authorization from the Board or a duly authorized committee of the Board under Delaware law;
•A declaration that, so long as the Board is evenly divided regarding the election at the Annual Meeting, no officer, employee, advisor or agent of the Company may take action on behalf of the Company for the purpose of directly or indirectly supporting either the LHMT Plaintiffs or the CCDL Defendants in connection with the election at the Annual Meeting;
•A declaration that actions purportedly taken by the CCDL Defendants on behalf of the Company without proper authorization were unauthorized, invalid and void;
•A permanent injunction prohibiting the CCDL Defendants from taking any action or purporting to take any action on behalf of the Company without proper authorization; and
•A permanent injunction specifying that the Company and its officers, employees agents and advisors in their capacity as such shall remain neutral in any electoral dispute between the LHMT Plaintiffs and the CCDL Defendants.
Finally, the LHMT Plaintiffs moved for a temporary restraining order to prevent the CCDL Defendants from making any public statements in the name of or on behalf of the Company without proper authorization and from using Company resources to support any candidate for election at the Annual Meeting while the Board remains evenly divided. At a February 15, 2022, hearing on the LHMT Plaintiffs’ motion for a temporary restraining order, the Court of Chancery granted the LHMT Plaintiffs’ motion and ordered the parties to submit a form of order reflecting the Court’s modifications to the LHMT Plaintiffs’ proposed order. The LHMT Plaintiffs expect an order will be entered providing that none of the CCDL Defendants or any director, officer employee, advisor or agent of the Company or anyone acting in concert with them shall, absent written Board approval, make or issue (i) any public statement, press release, or disclosure pertaining to the proxy contest in the name of the Company, but may do so in their individual capacity, or (ii) take action on behalf of the Company or use Company resources to support any candidate. The Court declined to require the Company to make any revised disclosures.
Chilton, Corcoran, Drake and Lord Complaint
On February 11, 2022, General Chilton, Mr. Corcoran, Ms. Drake, and General Lord (collectively, the "CCDL Plaintiffs") filed suit against Mr. Lichtenstein, Mr. Henderson, Ms. McNiff, and Mr. Turchin (collectively, the “LHMT Defendants”) and SPH (SPH and the LHMT Defendants, collectively, “LHMTS Defendants”) in the Court of Chancery of the State of Delaware seeking, among other things, an order appointing a special committee of the Company’s Board, consisting of General Chilton, Mr. Corcoran, and General Lord, to manage the Company’s response to a proxy contest recently launched by SPH, Mr. Lichtenstein and his nominees (the "Proxy Contest") in light of the Board’s current deadlock regarding the upcoming annual election, or, alternatively, appointing a custodian to break the deadlock. The Company is a named plaintiff and a named nominal defendant in the lawsuit. The LHMTS Defendants dispute whether the CCDL Plaintiffs were authorized to name the Company as a plaintiff in the lawsuit. The CCDL Plaintiffs filed the lawsuit due to disagreements among the Company’s evenly divided eight-member Board, which consists of the four CCDL Plaintiffs and the four LHMT Defendants – relating to the election of directors at the Company’s 2022 Annual Meeting of Stockholders. The CCDL Plaintiffs also filed the lawsuit due to alleged actions by the LHMT Defendants that Plaintiffs contend constitute breaches of the Individual Defendants’ fiduciary duties. The CCDL Plaintiffs allege that Mr. Lichtenstein breached his fiduciary duties due to his alleged engaging in unauthorized communications regarding the Company’s merger with Lockheed Martin; his alleged actions relating to the Company’s internal investigation into his alleged inappropriate behavior and conduct, and his alleged attempts to guarantee his re-nomination to the Company's Board regardless of the investigation’s outcome. The lawsuit further alleges that all the LHMT Defendants breached their fiduciary duties by participating in discussions regarding, and voting on, matters in which they are allegedly self-interested, and by allegedly failing to disclose material information about Mr. Lichtenstein’s intent and actions to take control of the Company in the Schedule 13D Amendments filed on February 1 and February 8. Finally, the CCDL Plaintiffs allege that SPH aided and abetted those breaches of fiduciary duty. The CCDL Plaintiffs further seek (i) a declaration that the LHMT Defendants are all interested with respect to the proxy contest, (ii) a declaration that the LHMT Defendants breached their fiduciary duties, as well as compensatory damages; (iii) removal of Mr. Lichtenstein as a director as a consequence for alleged breaches of his fiduciary duty of loyalty, pursuant to 8 Del. C. § 225(c); and (iv) a declaration that SPH violated the advanced notice bylaw by allegedly failing to include the requisite disclosures in the notice of nomination.
Asbestos Litigation
The Company has been, and continues to be, named as a defendant in lawsuits alleging personal injury or death and seeking various monetary damages due to exposure to asbestos in building materials, products, or in manufacturing operations. The majority of cases are pending in Illinois state courts. There were 127 asbestos cases pending as of December 31, 2021.
Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is generally unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. The aggregate settlement costs and legal and administrative fees associated with the Company’s asbestos litigation has been immaterial for the last three years. As of December 31, 2021, the Company has accrued an immaterial amount related to pending claims.
United States ex. rel. Markus vs. Aerojet Rocketdyne Holdings
In the case captioned United States ex. rel. Markus vs. Aerojet Rocketdyne Holdings, Inc. et al., Case No. 2:15-CV-02245- WBS-AC, the Department of Justice completed its review of the case and declined to intervene in June 2018. The case was originally filed under seal in the U.S. District Court, Eastern District of California in September 2017 and alleged causes of action against the Company based on false claims, retaliation, and wrongful termination of employment seeking injunctive relief, civil penalties, and compensatory and punitive damages. In February 2019, the Company filed a Motion to Dismiss the False Claims Act ("FCA") counts of the complaint and a Motion to Compel Arbitration on the employment based claims. In May 2019, the court dismissed one count of the FCA claim, denied the motion to dismiss the remaining FCA counts, and moved the employment based claims to arbitration. In September 2021, each party filed a motion for summary judgment. In February 2022, the Court denied Relator’s motion for summary judgment in full and granted the Company’s motion for summary judgment in part. Specifically, the Court rejected Relator’s false certification allegations in their entirety while also significantly diminishing the number of U.S. government contracts at issue in the litigation, which number excludes both the majority of contracts specified in Relator’s Second Amended Complaint ("SAC") as well as numerous contracts regarding which Relator purported to make claims but that were not specified in the SAC. The Court found disputed issues of material fact with regard to the remaining contracts. The Company continues to vigorously contest the complaint’s allegations and has not recorded any liability for this matter as of December 31, 2021.
City of Wabash, Indiana v. Aerojet Rocketdyne Holdings
On November 15, 2021, a lawsuit entitled City of Wabash, Indiana v. Aerojet Rocketdyne Holdings, Inc., Case No. 3:21-cv-878 was filed in the United States District Court for the Northern District of Indiana against the Company alleging causes of action under the Comprehensive Environmental Response Compensation and Liability Act and the Indiana Environmental Legal Action Statute and seeking damages, reasonable attorneys’ fees and costs. The action was served on the Company on January 11, 2022. The Company will vigorously contest the complaint’s allegations and has not recorded any liability for this matter as of December 31, 2021.
b. Environmental Matters
The Company is involved in approximately 40 environmental matters under the Comprehensive Environmental Response Compensation and Liability Act, the Resource Conservation Recovery Act, and other federal, state, and local laws relating to soil and groundwater contamination, hazardous waste management activities, and other environmental matters at some of its current and former facilities. The Company is also involved in a number of remedial activities at third party sites, not owned by the Company, where it is designated a potentially responsible party ("PRP") by either the U.S. Environmental Protection Agency ("EPA") and/or a state agency. In many of these matters, the Company is involved with other PRPs. In some instances, the Company’s liability and proportionate share of costs have not been determined largely due to uncertainties as to the nature and extent of site conditions and the Company’s involvement. While government agencies frequently claim PRPs are jointly and severally liable at such sites, in the Company’s experience, interim and final allocations of liability and costs are generally made based on relative contributions of waste or contamination. Anticipated costs associated with environmental remediation that are probable and estimable are accrued. In cases where a date to complete remedial activities at a particular site cannot be determined by reference to agreements or otherwise, the Company projects costs over an appropriate time period not exceeding 15 years. In such cases, generally the Company does not have the ability to reasonably estimate environmental remediation costs that are beyond this period. Factors that could result in changes to the Company’s estimates include completion of current and future soil and groundwater investigations, new claims, future agency demands, discovery of more or less contamination than expected, discovery of new contaminants, modification of planned remedial actions, changes in estimated time required to remediate, new technologies, and changes in laws and regulations.
As of December 31, 2021, the aggregate range of these anticipated environmental costs was $296.4 million to $453.8 million and the accrued amount was $296.4 million. See Note 8(c) for a summary of the environmental reserve activity. Of these accrued liabilities, approximately 98% relates to the Company’s U.S. government contracting business and a portion of this liability is recoverable. The significant environmental sites are discussed below. The balance of the accrued liabilities, which are not recoverable from the U.S. government, relate to other sites for which the Company’s obligations are probable and estimable.
Sacramento, California Site
In 1989, a federal district court in California approved a Partial Consent Decree ("PCD") requiring Aerojet Rocketdyne, among other things, to conduct a Remedial Investigation and Feasibility Study to determine the nature and extent of impacts due to the release of chemicals from the Sacramento, California site, monitor the American River and offsite public water supply wells, operate Groundwater Extraction and Treatment facilities that collect groundwater at the site perimeter, and pay certain government oversight costs. The primary chemicals of concern for both on-site and off-site groundwater are trichloroethylene, perchlorate, and n-nitrosodimethylamine. A 2002 PCD revision (a) separated the Sacramento site into multiple operable units to allow quicker implementation of remedies for critical areas; (b) required the Company to guarantee up to $75 million (in addition to a prior $20 million guarantee) to assure that Aerojet Rocketdyne’s Sacramento remediation activities are fully funded; and (c) removed approximately 2,600 acres of non-contaminated land from the EPA superfund designation. Obligations under the $75 million aggregate guarantee are limited to $10 million in any year. Both the $75 million aggregate guarantee and the $10 million annual limitation are subject to adjustment annually for inflation.
Aerojet Rocketdyne is involved in various stages of soil and groundwater investigation, remedy selection, design, construction, operation and maintenance associated with the operable units, all of which are conducted under the direction and oversight of the EPA, including unilateral administrative orders, and the California Department of Toxic Substances Control ("DTSC") and Regional Water Quality Control Board, Central Valley Region ("RWQCB"). On September 22, 2016, the EPA completed its first five-year remedy review of the Sacramento superfund site. The five-year review required by statute and regulation applies to all remedial actions which result in hazardous substances above levels that allow unlimited use and unrestricted exposure. The Company worked with the EPA to address and remedy the findings of the 2016 five-year remedy review. On September 15, 2021, the EPA issued its second five-year remedy review and concluded that the remedies are functioning as intended for the soil and groundwater contamination and that the vapor intrusion investigation and mitigation activities are protective against vapor intrusion risks. The Company is working with the EPA, DTSC, and RWQCB on the implementation of required onsite land use restrictions.
The entire southern portion of the site known as Rio Del Oro was under state orders issued in the 1990s from DTSC and the RWQCB to investigate and remediate soil and groundwater contamination. In 2008, the DTSC released all but approximately 400 acres of the Rio Del Oro property from DTSC’s environmental orders regarding soil contamination although the property remains subject to the RWQCB’s orders to investigate and remediate groundwater environmental contamination emanating offsite from the property.
As of December 31, 2021, the estimated range of anticipated costs discussed above for the Sacramento, California site was $214.7 million to $347.7 million and the accrued amount was $214.7 million included as a component of the Company’s environmental reserves. Expenditures associated with this matter are partially recoverable. See Note 8(c) below for further discussion on recoverability.
Baldwin Park Operable Unit
As a result of its former Azusa, California operations, in 1994, Aerojet Rocketdyne was named a PRP by the EPA in the area of the San Gabriel Valley Basin superfund site known as the BPOU. In 2002, Aerojet Rocketdyne, along with seven other PRPs (the "Cooperating Respondents") signed a project agreement with the San Gabriel Basin Water Quality Authority, the Main San Gabriel Basin Watermaster, and five water companies. The 2002 project agreement terminated in 2017 and the parties executed a project agreement which became operational on May 9, 2017. The agreement has a ten-year term and requires the Cooperating Respondents to fund through an escrow account the ongoing operation, maintenance, and administrative costs of certain treatment and water distribution facilities owned and operated by the water companies. There are also provisions in the project agreement for maintaining financial assurance.
Pursuant to the 2017 agreement with the remaining Cooperating Respondents, Aerojet Rocketdyne's current share of future BPOU costs will be approximately 74%.
As part of Aerojet Rocketdyne’s sale of its Electronics and Information Systems ("EIS") business to Northrop Grumman Corporation ("Northrop") in October 2001, the EPA approved a prospective purchaser agreement with Northrop to absolve it of a pre-closing liability for contamination caused by the Azusa, California operations, which liability remains with Aerojet Rocketdyne. As part of that agreement, the Company agreed to provide a $25 million guarantee of its obligations under the project agreement.
As of December 31, 2021, the estimated range of anticipated costs was $64.7 million to $78.0 million and the accrued amount was $64.7 million included as a component of the Company’s environmental reserves. Expenditures associated with this matter are partially recoverable. See Note 8(c) below for further discussion on recoverability.
c. Environmental Reserves and Estimated Recoveries
Environmental Reserves
The Company reviews on a quarterly basis estimated future remediation costs and has an established practice of estimating environmental remediation costs over a fifteen year period, except for those environmental remediation costs with a specific contractual term. Environmental liabilities at the BPOU site are currently estimated through the term of the project agreement, which expires in May 2027. As the period for which estimated environmental remediation costs lengthens, the reliability of such estimates decreases. These estimates consider the investigative work and analysis of engineers, outside environmental consultants, and the advice of legal staff regarding the status and anticipated results of various administrative and legal proceedings. In most cases, only a range of reasonably possible costs can be estimated. In establishing the Company’s reserves, the most probable estimate is used when determinable; otherwise, the minimum amount is used when no single amount in the range is more probable. Accordingly, such estimates can change as the Company periodically evaluates and revises these estimates as new information becomes available. The Company cannot predict whether new information gained as projects progress will affect the estimated liability accrued. The timing of payment for estimated future environmental costs is influenced by a number of factors, such as the regulatory approval process and the time required designing, constructing, and implementing the remedy.
The following table summarizes the Company’s environmental reserve activity:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Aerojet Rocketdyne- Sacramento | | Aerojet Rocketdyne- BPOU | | Other Aerojet Rocketdyne Sites | | Total Aerojet Rocketdyne | | Other | | Total Environmental Reserve |
| (In millions) |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
December 31, 2018 | $ | 207.4 | | | $ | 103.8 | | | $ | 12.4 | | | $ | 323.6 | | | $ | 4.3 | | | $ | 327.9 | |
Additions | 17.0 | | | (0.8) | | | 0.3 | | | 16.5 | | | 0.2 | | | 16.7 | |
Expenditures | (20.8) | | | (13.4) | | | (0.9) | | | (35.1) | | | (0.3) | | | (35.4) | |
December 31, 2019 | 203.6 | | | 89.6 | | | 11.8 | | | 305.0 | | | 4.2 | | | 309.2 | |
Additions | 30.9 | | | (0.2) | | | — | | | 30.7 | | | 1.7 | | | 32.4 | |
Expenditures | (26.1) | | | (13.2) | | | (1.2) | | | (40.5) | | | (0.5) | | | (41.0) | |
December 31, 2020 | 208.4 | | | 76.2 | | | 10.6 | | | 295.2 | | | 5.4 | | | 300.6 | |
Additions | 28.8 | | | 2.5 | | | 3.7 | | | 35.0 | | | 0.3 | | | 35.3 | |
Expenditures | (22.5) | | | (14.0) | | | (2.5) | | | (39.0) | | | (0.5) | | | (39.5) | |
December 31, 2021 | $ | 214.7 | | | $ | 64.7 | | | $ | 11.8 | | | $ | 291.2 | | | $ | 5.2 | | | $ | 296.4 | |
The effect of the final resolution of environmental matters and the Company’s obligations for environmental remediation and compliance cannot be accurately predicted due to the uncertainty concerning both the amount and timing of future expenditures and due to regulatory or technological changes. The Company continues its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies.
Estimated Recoveries
On January 12, 1999, Aerojet Rocketdyne and the U.S. government reached a settlement agreement ("Global Settlement") covering environmental costs associated with the Company's Sacramento site and its former Azusa site. Pursuant to the Global Settlement, the Company can recover 88% of its environmental remediation costs through the establishment of prices for Aerojet Rocketdyne's products and services sold to the U.S. government. Additionally, in conjunction with the sale of the EIS business in 2001, Aerojet Rocketdyne entered into an agreement with Northrop (the "Northrop Agreement") whereby Aerojet Rocketdyne is reimbursed by Northrop for a portion of environmental expenditures eligible for recovery under the Global Settlement, subject to an annual billing limitation of $6.0 million and a cumulative limitation of $189.7 million which was reached in June 2017. The following table summarizes the Northrop Agreement activity (in millions):
| | | | | |
Total reimbursable costs under the Northrop Agreement | $ | 189.7 | |
Amount reimbursed to the Company through December 31, 2021 | (149.2) | |
Receivable from Northrop included in the balance sheet at December 31, 2021 | $ | 40.5 | |
Environmental remediation costs are primarily incurred by the Company's Aerospace and Defense segment, and certain of these costs are recoverable from the Company's contracts with the U.S. government. The Company currently estimates approximately 12% of its future Aerospace and Defense segment environmental remediation costs will not likely be reimbursable and are expensed. Allowable environmental remediation costs are charged to the Company’s contracts with the U.S. government as the costs are incurred. Because these costs are recovered through forward-pricing arrangements, the ability of Aerojet Rocketdyne to continue recovering these costs from the U.S. government depends on Aerojet Rocketdyne’s sustained business volume from U.S. government contracts and programs.
While the Company continues to seek an arrangement with the U.S. government to recover environmental expenditures in excess of the reimbursement ceiling identified in the Global Settlement, there can be no assurances that such a recovery will be obtained, or if not obtained, that such unreimbursed environmental expenditures will not have a materially adverse effect on the Company’s operating results, financial condition, and/or cash flows.
Environmental reserves and estimated recoveries impact on the consolidated statements of operations
The following table summarizes the financial information for the impact of environmental reserves and recoveries to the consolidated statements of operations: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
| | | | | | | |
| | | | | | | |
Expense to consolidated statement of operations | $ | 4.1 | | | $ | 4.3 | | | $ | 2.1 | | | |
| | | | | | | |
d. Arrangements with Off-Balance Sheet Risk
As of December 31, 2021, arrangements with off-balance sheet risk consisted of:
•$27.8 million in outstanding commercial letters of credit, the majority of which may be renewed, primarily to collateralize obligations for environmental remediation and insurance coverage.
•$56.6 million in outstanding surety bonds to primarily satisfy indemnification obligations for environmental remediation coverage.
•Up to $120.0 million aggregate in guarantees by the Company of Aerojet Rocketdyne’s obligations to U.S. government agencies for environmental remediation activities.
•Guarantees, jointly and severally, by the Company’s material domestic subsidiaries of their obligations under the Senior Credit Facility.
In addition to the items discussed above, the Company has and will from time to time enter into certain types of contracts that require the Company to indemnify parties against potential third-party and other claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnification to purchasers of its businesses or assets including, for example, claims arising from the operation of the businesses prior to disposition, and liability to investigate and remediate environmental contamination existing prior to disposition; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for claims arising from the use of the applicable premises; and (iii) certain agreements with officers and directors, under which the Company may be required to indemnify such persons for liabilities arising out of their relationship with the Company. The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated.
Additionally, the Company has open purchase orders and other commitments to suppliers, subcontractors, and other outsourcing partners for equipment, materials, and supplies in the normal course of business. These amounts are based on volumes consistent with anticipated requirements to fulfill purchase orders or contracts for product deliveries received, or expected to be received, from customers. A substantial portion of these amounts are recoverable through the Company's contracts with the U.S. government.
The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are a one-year standard warranty for parts, workmanship, and compliance with specifications. On occasion, the Company has made commitments beyond the standard warranty obligation. While the Company has contracts with warranty
provisions, there is not a history of any significant warranty claims experience. A reserve for warranty exposure is made on a product by product basis when it is both estimable and probable. These costs are included in the program’s estimate at completion and are expensed in accordance with the Company’s revenue recognition methodology as allowed under GAAP for that particular contract.
Note 9. Stockholders’ Equity
a. Preferred Stock
As of December 31, 2021 and 2020, 15.0 million shares of preferred stock were authorized and none were issued or outstanding.
b. Common Stock
As of December 31, 2021, the Company had 150.0 million authorized shares of common stock, par value $0.10 per share, of which 80.1 million shares were issued and outstanding, and 18.4 million shares were reserved for future issuance for the exercise of stock options (seven year contractual life) and restricted stock (no maximum contractual life), payment of awards under stock-based compensation plans, and conversion of the Company’s convertible debt.
c. Treasury Stock
As of December 31, 2021 and 2020, the Company had 2.1 million of its common shares classified as treasury stock. During 2020, the Company repurchased 1.3 million of its common shares at a cost of $51.7 million. Treasury stock is stated at cost (first-in, first-out basis). The Company reflects stock repurchases in its financial statements on a "settlement" basis
d. Dividends
On December 19, 2020, the Company’s Board of Directors declared the one-time Pre-Closing Dividend in cash of $5.00 per share (including shares underlying the 2¼% Notes participating on an as-converted basis). The Pre-Closing Dividend was paid on March 24, 2021, to the holders of the Company’s shares and 2¼% Notes as of the close of business on March 10, 2021.
e. Stock-based Compensation
The following table summarizes stock-based compensation expense by type of award:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
SARs | $ | 2.0 | | | $ | 8.1 | | | $ | 11.4 | | | |
Restricted stock and restricted stock units, service based | 6.3 | | | 8.6 | | | 5.2 | | | |
Restricted stock and restricted stock units, performance based | 11.9 | | | 12.6 | | | 9.4 | | | |
Employee stock purchase plan ("ESPP") | 0.5 | | | 1.1 | | | 0.9 | | | |
Stock options | — | | | 1.0 | | | 0.4 | | | |
Total stock-based compensation expense | $ | 20.7 | | | $ | 31.4 | | | $ | 27.3 | | | |
Stock Appreciation Rights: As of December 31, 2021, a total of 0.8 million SARs were outstanding. SARs granted to employees generally vest in one-third increments at one year, two years, and three years from the date of grant and have a seven year contractual life. SARs granted to directors of the Company typically vest over a one year service period (half after six months and half after one year) and have a seven year contractual life. These awards are similar to the Company’s employee stock options, but are settled in cash rather than in shares of common stock, and are classified as liability awards. Compensation cost for these awards is determined using a fair-value method and remeasured at each reporting date until the date of settlement.
The following table summarizes the status of the Company’s SARs:
| | | | | | | | | | | | | | | | | | | | | | | |
| SARs (In millions) | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value (In millions) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Outstanding at December 31, 2020 | 0.9 | | | $ | 24.09 | | | | | |
| | | | | | | |
| | | | | | | |
Canceled | (0.1) | | | 30.51 | | | | | |
Outstanding at December 31, 2021 | 0.8 | | | $ | 24.46 | | | 3.2 | | $ | 18.5 | |
Exercisable at December 31, 2021 | 0.7 | | | $ | 23.54 | | | 3.1 | | $ | 17.2 | |
Expected to vest at December 31, 2021 | 0.1 | | | $ | 32.39 | | | 4.2 | | $ | 1.2 | |
The weighted average grant date fair value for SARs granted in 2019 was $37.26. The exercise price of the SARS outstanding on March 10, 2021, was reduced by the Pre-Closing Dividend of $5.00 per share. The total intrinsic value for SARs liabilities paid in 2021, 2020, and 2019 was $0.8 million, $7.6 million, and $4.3 million, respectively. As of December 31, 2021,
there was $0.1 million of unrecognized stock-based compensation related to nonvested SARs that is expected to be recognized over an estimated weighted-average amortization period of two months.
Restricted Stock, service-based: As of December 31, 2021, a total of 0.1 million shares of service-based restricted stock were outstanding which vest based on years of service. Restricted shares are granted to employees and directors of the Company. The fair value was based on the closing market price of the Company’s common stock on the date of award and is being amortized on a straight line basis over the service period.
The following table summarizes the status of the Company’s service-based restricted stock: | | | | | | | | | | | |
| Service Based Restricted Stock (In millions) | | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2020 | 0.2 | | | $ | 39.90 | |
| | | |
| | | |
| | | |
| | | |
| | | |
Exercised | (0.1) | | | 36.61 | |
| | | |
Outstanding and expected to vest at December 31, 2021 | 0.1 | | | $ | 45.97 | |
| | | |
As of December 31, 2021, there was $1.7 million of unrecognized stock-based compensation related to nonvested service-based restricted stock that is expected to be recognized over an estimated weighted-average amortization period of ten months. At December 31, 2021, the intrinsic value of the service-based restricted stock outstanding and expected to vest was $4.8 million. The weighted average grant date fair values for service-based restricted stock granted in 2019 was $40.70.
Restricted Stock Units, service-based: As of December 31, 2021, a total of 0.2 million shares of service-based restricted stock units were outstanding which vest based on years of service. Restricted stock units are granted to employees of the Company. The fair value was based on the closing market price of the Company’s common stock on the date of award and is being amortized on a straight line basis over the service period.
The following table summarizes the status of the Company’s service-based restricted stock units: | | | | | | | | | | | |
| Service Based Restricted Stock Units (In millions) | | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2020 | 0.1 | | | $ | 46.00 | |
Granted | 0.1 | | | 48.61 | |
| | | |
| | | |
| | | |
| | | |
Outstanding and expected to vest at December 31, 2021 | 0.2 | | | $ | 47.10 | |
| | | |
As of December 31, 2021, there was $6.3 million of unrecognized stock-based compensation related to nonvested service-based restricted stock units that is expected to be recognized over an estimated weighted-average amortization period of twenty-eight months. At December 31, 2021, the intrinsic value of the service-based restricted stock units outstanding and expected to vest was $8.3 million.
Restricted Stock, performance-based Company metrics: As of December 31, 2021, a total of 0.3 million shares of performance-based restricted shares were outstanding. The performance-based restricted stock vests if the Company meets various operations and earnings targets set by the Organization & Compensation Committee of the Board of Directors. The fair value was based on the closing market price of the Company’s common stock on the date of award and is being amortized over the estimated service period to achieve the operations and earnings targets.
The following table summarizes the status of the Company’s performance-based restricted stock: | | | | | | | | | | | |
| Performance Based Restricted Stock (In millions) | | Weighted Average Grant Date Fair Value |
| | | |
| | | |
| | | |
| | | |
Outstanding at December 31, 2020 | 0.5 | | | $ | 36.59 | |
| | | |
Exercised | (0.1) | | | 27.76 | |
Canceled | (0.1) | | | 41.60 | |
Outstanding at December 31, 2021 | 0.3 | | | $ | 40.31 | |
Expected to vest at December 31, 2021 | 0.3 | | | $ | 38.71 | |
As of December 31, 2021, there was $1.8 million of unrecognized stock-based compensation related to nonvested performance-based restricted stock that is expected to be recognized over an estimated weighted-average amortization period of twelve months. At December 31, 2021, the intrinsic value of the performance-based restricted stock outstanding was $15.8 million and the intrinsic value of the performance-based restricted stock expected to vest was $12.8 million. The weighted average grant date fair values for performance-based restricted stock granted in 2019 was $37.27.
Restricted Stock Units, performance-based Company metrics: As of December 31, 2021, a total of 1.0 million shares of performance-based restricted stock units were outstanding. The performance-based restricted stock units vest if the Company meets various operations and earnings targets set by the Organization & Compensation Committee of the Board of Directors. The fair value was based on the closing market price of the Company’s common stock on the date of award and is being amortized over the estimated service period to achieve the operations and earnings targets.
The following table summarizes the status of the Company’s performance-based restricted stock units: | | | | | | | | | | | |
| Performance Based Restricted Stock Units (In millions) | | Weighted Average Grant Date Fair Value |
| | | |
| | | |
| | | |
| | | |
Outstanding at December 31, 2020 | 0.4 | | | $ | 50.00 | |
Granted | 0.7 | | | 48.64 | |
| | | |
Canceled | (0.1) | | | 51.10 | |
Outstanding at December 31, 2021 | 1.0 | | | $ | 49.12 | |
Expected to vest at December 31, 2021 | 0.6 | | | $ | 49.15 | |
As of December 31, 2021, there was $18.0 million of unrecognized stock-based compensation related to nonvested performance-based restricted stock units that are expected to be recognized over an estimated weighted-average amortization period of twenty-seven months. At December 31, 2021, the intrinsic value of the performance-based restricted stock units outstanding was $45.0 million and the intrinsic value of the performance-based restricted stock expected to vest was $27.6 million.
Employee Stock Purchase Plan: The ESPP enables eligible employees the opportunity to purchase the Company’s common stock at a price not less than 85% of the fair market value of the common stock on the last day of the respective offering period. A maximum of 1.5 million shares are authorized for issuance. In July 2021, the ESPP was suspended until further notice. During 2021, 0.1 million shares were issued under the ESPP at an average price of $48.29. During 2020, 0.2 million shares were issued under the ESPP at an average price of $45.65. During 2019, 0.1 million shares were issued under the ESPP at an average price of $45.25.
Stock Options: As of December 31, 2021 and 2020, there were no stock options outstanding. The total intrinsic value for options exercised in 2020 and 2019 was $11.0 million and $0.8 million, respectively. The fair value of the stock option grant in 2019 was estimated using a Black-Scholes model with an expected life of seven years, volatility of 33.48%, and a risk-free rate of 2.62%. The Company did not grant stock options in 2021 and 2020.
Performance Stock Units: In March 2020, the Company granted the Executive Chairman 0.1 million performance stock units that vest according to the attainment of share prices ranging from $57.80 per share to $67.85 per share of the Company's stock. The performance stock units were valued at a weighted average price of $37.12 using a Monte Carlo model. The Company recognized the grant-date fair value of these awards as stock-based compensation expense ratably over the estimated vesting period based on the number of awards expected to vest at each reporting date or earlier if the market condition was satisfied. As of December 31, 2021, there was no unrecognized stock-based compensation related to nonvested performance stock units. At December 31, 2021, the intrinsic value of the performance stock units outstanding was $3.3 million. The following table presents the weighted average assumptions used to value the units for 2020: | | | | | | | |
| | | |
Expected life (in years) | 0.67 | | |
Volatility | 35.41 | % | | |
Risk-free interest rate | 0.72 | % | | |
Dividend yield | — | % | | |
Valuation Assumptions: The following table presents the weighted average assumptions used to value the SARs:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
Expected life (in years) | 3.2 | | 0.7 | | 4.9 | | |
Volatility | 38.17 | % | | 48.30 | % | | 34.79 | % | | |
Risk-free interest rate | 0.94 | % | | 0.11 | % | | 1.69 | % | | |
Dividend yield | — | % | | — | % | | — | % | | |
Expected Term: The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards and vesting schedules.
Expected Volatility: The fair value of stock-based payments was determined using the Black-Scholes model with a volatility factor based on the Company’s historical stock prices. The range of expected volatility used in the Black-Scholes model was 28.04% to 40.00% as of December 31, 2021.
Risk-Free Interest Rate: The Company bases the risk-free interest rate used in the Black-Scholes model on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. The range of risk-free interest rates used in the Black-Scholes model was 0.38% to 1.27% as of December 31, 2021.
Note 10. Operating Segments and Related Disclosures
The Company’s operations are organized into two operating segments based on different products and customer bases: Aerospace and Defense, and Real Estate. Sales to significant customers and other concentrations information is presented in Note 1. The accounting policies of the operating segments are the same as those presented in the summary of significant accounting policies in Note 1.
The Company evaluates its operating segments based on several factors, of which the primary financial measure is segment performance. Segment performance represents net sales less applicable costs, expenses and unusual items relating to the segment operations. Segment performance excludes corporate income and expenses, unusual items not related to the segment operations, interest expense, interest income, and income taxes.
The following table presents selected financial information for each reportable segment:
| | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| | | | | | | |
| 2021 | | 2020 | | 2019 | | |
| (In millions) |
Net Sales: | | | | | | | |
Aerospace and Defense | $ | 2,179.3 | | | $ | 2,069.4 | | | $ | 1,974.0 | | | |
Real Estate | 8.7 | | | 3.3 | | | 7.5 | | | |
Total Net Sales | $ | 2,188.0 | | | $ | 2,072.7 | | | $ | 1,981.5 | | | |
Segment Performance: | | | | | | | |
Aerospace and Defense | $ | 282.3 | | | $ | 264.2 | | | $ | 249.1 | | | |
Environmental remediation provision adjustments | (3.8) | | | (2.7) | | | (1.9) | | | |
| | | | | | | |
GAAP/CAS retirement benefits expense difference | 11.5 | | | 14.7 | | | 22.4 | | | |
Unusual items | (4.1) | | | (0.6) | | | (0.3) | | | |
Aerospace and Defense Total | 285.9 | | | 275.6 | | | 269.3 | | | |
Real Estate | 2.9 | | | (1.8) | | | 2.1 | | | |
Total Segment Performance | $ | 288.8 | | | $ | 273.8 | | | $ | 271.4 | | | |
Reconciliation of segment performance to income before income taxes: | | | | | | | |
Segment performance | $ | 288.8 | | | $ | 273.8 | | | $ | 271.4 | | | |
Interest expense | (20.1) | | | (30.1) | | | (35.7) | | | |
Interest income | 2.5 | | | 6.3 | | | 15.5 | | | |
Stock-based compensation | (20.7) | | | (31.4) | | | (27.3) | | | |
Corporate retirement benefits expense | (6.6) | | | (7.5) | | | (7.2) | | | |
Corporate and other | (23.6) | | | (23.4) | | | (24.8) | | | |
Unusual items | (25.3) | | | (7.5) | | | — | | | |
Income before income taxes | $ | 195.0 | | | $ | 180.2 | | | $ | 191.9 | | | |
Aerospace and Defense | $ | 37.3 | | | $ | 54.6 | | | $ | 42.9 | | | |
Real Estate | — | | | — | | | — | | | |
Corporate | — | | | — | | | 1.0 | | | |
Capital Expenditures | $ | 37.3 | | | $ | 54.6 | | | $ | 43.9 | | | |
Aerospace and Defense | $ | 60.5 | | | $ | 64.2 | | | $ | 72.9 | | | |
Real Estate | 0.7 | | | 0.8 | | | 1.2 | | | |
Corporate | 0.2 | | | 0.3 | | | 0.4 | | | |
Depreciation and Amortization | $ | 61.4 | | | $ | 65.3 | | | $ | 74.5 | | | |
| | | | | | | | | | | | | | | |
| | | | | As of December 31, |
| | | | | 2021 | | 2020 |
| | | | | (In millions) |
Assets: | | | | | | | |
Aerospace and Defense | | | | | $ | 1,499.5 | | | $ | 1,484.9 | |
Real Estate | | | | | 135.1 | | | 133.9 | |
Operating segment assets | | | | | 1,634.6 | | | 1,618.8 | |
Corporate | | | | | 799.0 | | | 1,281.1 | |
Total Assets | | | | | $ | 2,433.6 | | | $ | 2,899.9 | |